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GENERAL INTRODUCTION 
Introduction 
Outbreaks of porcine reproductive and respiratory syndrome (PRRS) have 
inflicted huge financial losses on the global pig producing community since first 
observed in North America, Europe, and Asia in 1980's and early 1990's. At present, 
PRRS continues to elude our best efforts at prevention and control. The etiologic agent, 
PRRS virus, is an enveloped virus possessing a positive sense, single stranded. RNA 
genome. On the basis of similarities in genomic organization and replication strategies, 
PRRS virus is classified in the family Arteriviridae, order Nidoviridae along with lactate 
dehydrogenase-elevating virus (LDV), equine arteritis virus (EAV). and simian 
hemorrhagic fever virus (SHFV). The arteriviruses were all identified in the recent past: 
EAV was isolated in 1957 (Doll et al., 1957a, b), LDV in 1960 (Riley et al., 1960), SHFV 
in 1964 (Palmer et al., 1968; Tauraso, et al., 1968) and PRRSV in 1991 (Wensvoort et al., 
1991). Viruses in this group are generally considered to have a narrow host range, and 
frequently produce asymptomatic, persistent infections in host species, in some cases for 
the lifetime of the host, despite an active immune response. As in the case of other 
arteriviruses, persistent PRRSV infection is well recognized and virus has been isolated 
from pigs up to 157 days post inoculation (Wills et al., 1997). 
Arterivirus are characterized by a high degree of genetic and antigenic variation. 
Given our understanding of the error-prone process of RNA replication and its lack of 
transcription and replication fidelity, viral diversity among the arteriviruses is not 
surprising. However, our understanding of the biological ramifications of virus diversity 
is incomplete. From experience, we know that mutations may produce changes of which 
we approve, as for example, in the attenuation of a virulent poliovirus and subsequent use 
as a vaccine (Bouchard et al., 1995), or result in a turn for the worse, as occurred when 
mutations produced outbreaks of highly virulent avian influenza in Pennsylvania in 1983 
(Kawaoka and Webster, 1985; Webster et al., 1985). It follows that understanding the 
source and degree of viral diversity is important because of potential virus-host 
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interactions that impact virus virulence, host immunity, and even our ability to detect and 
diagnose the infection. For these reasons, understanding variation among PRRS viruses 
has become central to PRRS virology. 
Dissertation Organization 
This dissertation is organized into four chapters. The first chapter contains the 
general introduction and describes the organization of the dissertation. The second 
chapter consists of a literature review entitled, "Evolution of porcine reproductive and 
respiratory syndrome (PRRS) virus and other arteriviruses" to be submitted for 
publication in Animal Health Reviews. The third chapter is a paper that describes the 
research conducted in the course of completing this degree and is entitled, "Evolution of 
porcine reproductive and respiratory syndrome (PRRS) virus during sequential pig 
passages." This paper has been submitted to the Journal of Virology. The doctoral 
candidate is the first author of the paper. Co-authors are K-J Yoon, DVM, Ph.D., Jeff 
Zimmerman. DVM, Ph.D., Philip Dixon, Ph.D., Michael P. Murtaugh, DVM, Ph.D., and 
Karen M. Harmon, Ph.D. Co-authors provided advice and assistance in the design, 
execution, and analysis of the experiment. The last chapter includes the general 
conclusions covering the conclusion and future studies. 
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LITERATURE REVIEW 
EVOLUTION OF PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME VIRUS (PRRSV) AND OTHER ARTERIVIRUSES 
Introduction 
Contemporary studies in virus evolution have been given impetus by the 
development of molecular tools and the growing realization that even slight changes in 
the genome of a virus may cause important changes in its pattern of disease (Morse. 
1993; Murphy and Nathanson, 1994). These changes may be for the better, as for 
example, in the attenuation of a virulent poliovirus and its subsequent use as a vaccine 
(Bouchard et al., 1995), or for the worse, as occurred when mutations produced outbreaks 
of highly virulent avian influenza in Pennsylvania in 1983 (Kawaoka and Webster, 1985; 
Webster et al., 1986). Virus variants have the potential to differ from the parent in 
virulence, tissue tropism, ability to persist in the host, and/or adaptation to new hosts 
(Boyd et al., 1993; Faaberg et al., 1995b; Jarousse et al., 1994a, b; Seif et al.. 1985; 
Subbarao et al., 1993). Although the majority of mutations produce no clinically 
meaningful effects, it is the potential for genetic mutation to disastrously impact the 
clinical and ecological expression of a virus that drives research on virus evolution. 
Given the error-prone process of RNA replication resulting from the inability of 
RNA-dependent RNA polymerases to proof-read, the continual emergence of new 
variants (quasispecies) within an RNA virus species is to be expected. Unquestionably, 
this process has proceeded for millennia in a relentless, but generally benign fashion. 
Nonetheless, the implications of virus mutation and evolution for immunity and 
vaccinology. pathology and diagnostics, epidemiology and disease ecology are 
potentially profound. In this paper we review the current state of knowledge regarding 
mutation and evolution of porcine reproductive and respiratory syndrome (PRRS) virus. 
For the reasons given above, understanding the source and degree of variation among 
PRRS viruses has become central to PRRS virology. The discussion will be placed 
within the larger context of mechanisms of genetic and antigenic variation within the 
family Arteriviridae. 
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The Arteriviruses 
The arteriviruses are enveloped viruses possessing a single-stranded, non-
segmented, positive sense RNA genome: equine arteritis virus (EAV), lactate 
dehydrogenase-elevating virus (LDV) of mice, simian hemorrhagic fever virus (SHFV). 
and porcine reproductive and respiratory syndrome virus (PRRSV). These viruses were 
all identified in the recent past, i.e., EAV was first isolated in 1957 (Doll et al., 1957a, b). 
LDV in 1960 (Riley et al., I960), SHFV in 1964 (Palmer et al., 1968; Tauraso. et al., 
1968) and PRRSV in 1991 (Wensvoort et al., 1991). 
PRRSV infection causes reproductive disease in pregnant sows and respiratory 
distress in all ages of pigs (Christiansen et al., 1992; Halbur et al., 1996; Hooper et al.. 
1992; Pol et al., 1991; Rossow et al., 1994; Yoon et al.. 1992). Persistence is a 
characteristic of PRRSV infection and virus has been isolated from pigs for up to 157 
days post inoculation (Wills et al., 1997). Two divergent PRRS viruses, the Lelystad 
(PRRS-LV) virus representing the European prototype and VR-2332 (PRRS-VR-2332) 
representing the prototype of North American prototype were isolated at early 1990's 
(Benfield. et al., 1992; Wensvoort et al., 1991) 
EAV is infectious for horses, donkeys, and mules (Paweska et al., 1997). 
Infection is frequently inapparent, but EAV may cause abortion in pregnant mares and 
interstitial pneumonia, primarily in foals (Bryans et al.. 1957; McCollum et al., 1971; 
Vaala et al, 1992). EAV frequently localizes in the male reproductive tract and stallions 
may shed virus in semen for months to years (Timoney and McCollum 1993). 
LDV infects the house mouse (Mus musculus) and the Asian ricefield mouse (Mus 
carolï) (Rowson, 1980). In these species, infection with a non-neuropathogenic strain 
(LDV-P) is asymptomatic and persistent, with lifelong viremia and elevated serum levels 
of lactate dehydrogenase (Notins, 1965; Brinton et al., 1983). The viremia persists 
despite the development of specific immunity against LDV (Onyekaba et al., 1989; van 
den Broek et al., 1997). On the other hand, neuropathogenic strains (LDV-C) could 
induce a fatal paralytic disease, age-dependent poliomyelitis (ADPM) in 
immunocompromised C58 and AKR mice (Chen et al., 1998a; Contag et al., 1986). 
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SHFV, the least studied of the arteriviruses, is infectious for many species of 
primates and shows a species-dependent disease pattern, i.e., asymptomatic, persistent 
infection, and lifelong viremia in non-macaque species, but fatal infection in macaque 
species (Gravell et al., 1986; Palmer et al., 1968; Tauraso et al., 1968). 
Taxonomy of arteriviruses 
In 1996, at the 10th International Congress of Virology, PRRSV, EAV, LDV, and 
SHFV were placed in the genus arterivirus, family Arterivirdae (Pringle, 1996). In 
addition, it was proposed that families Coronavirdae and Arterivirdae be classified in 
order Nidovirales (Table 1). Arterivirus is the only genus in family Artriviridae, while 
the Coronaviridae contains two genera, genus coronavirus and genus torovirus, 
composed of 11 and 2 viral species, respectively (Cavanagh, 1997). 
Table 1. Classification of families and species within order Nidovirales 
Family Genus Species Host 
Coronaviridae Coronavirus Avian infectious bronchitis virus Chicken 
Turkey coronavirus Turkey 
Feline infectious peritonitis virus Cat 
Canine coronavirus Dog 
Bovine coronavirus Cattle 
Human coronavirus 229E Human 
Human coronavirus OC43 Human 
Murine hepatitis virus Mouse 
Porcine transmissible gastroenteritis virus Pig 
Porcine epidemic diarrhea virus Pig 
Porcine haemagglutinating encephalomyelitis virus Pig 
Torovirus Berne virus Horse 
Breda virus Cattle 
Arteriviridae Arterivirus Equine arteritis virus Horse 
Lactate dehydrogenase-elevating virus Mouse 
Simian haemorrhagic fever virus Monkey 
Porcine reproductive and respiratory syndrome virus Pig 
(Modified from Cavanagh, 1997 and Siddell, 1995) 
6 
Similarities in genomic organization and replication strategies are the defining 
characteristics of the order Nidovirales. The name Nidovirales comes from the Latin 
'nidus,' meaning nest, and is meant to reflect a characteristic common to these viruses, 
i.e., the production of a 3' co-terminal nested set of subgenomic mRNAs for gene 
expression (Cavanagh 1997; Cavanagh et al., 1994). Specific features of viral 
morphology, genomic characteristics and size of viral protein are summarized in Table 2 
(Cavanagh, 1997). Both arterivirus and coronavirus are spherical, enveloped viruses, but 
based on traditional virus taxonomy, the morphological differences in outer appearance 
and symmetry of inner nucleocapsid have been used for the criteria to place them into 
two independent families. 
Morphology 
Arteriviruses are spherical and enveloped. Electron microscopic studies have 
estimated the diameter of intact arteriviruses at approximately 50 to 62, 55, 101, and 45 
nm for PRRSV, LDV, EAV and SHFV respectively, with a similar sized (20 to 30 nm) 
icosahedral nucleocapsid core. Arteriviruses lack surface projections, one of the 
significant features of coronaviruses (Benfield et al., 1992; Brinton-Damell and 
Plagemann. 1975; Dea et al., 1995; Horzinek and Wielink, 1975; Mardassi et al., 1994; 
Pol and Wagenaar, 1992; Wada et al., 1995). The buoyant density (g/cm3) in sucrose is 
approximately 1.13 to 1.17 for all arteriviruses (Benfield et al., 1992; Brinton-Damell and 
Plagemann, 1975; Hyllseth. 1970; Sagripanti, 1984; Wensvoort et al., 1992). 
Genome 
Except for SHFV, complete genomic sequences are now available for all 
prototype arteriviruses, i.e., the European Lelystad (PRRS-LV) and North American 
(PRRS-VR-2332) strains of PRRSV, the Bucyrus strain of EAV, and LDV-P and LDV-C 
strains of LDV (den Boon et al., 1991; Godeny et al., 1993; Meulengberg et al., 1993b; 
Nelsen et al., 1999; Palmer et al., 1995). For SHFV, part of open reading frame (ORF) 
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lb and all structural gene sequences have been reported (Chen and Plagemann, 1995; 
Smith et al., 1997; Wang et al., 1998). 
Arteriviruses possess a single-stranded, non-segmented, positive-sense RNA 
genome. The size of genomic RNA is 15.1 to 15.5, 14.1 to 14.2. and 13 kb for PRRSV, 
LDV, and EAV, respectively. The genes are arranged in a consistent order, i.e., 
beginning with the 5" non-coding region (NCR), then non-structural genes, structural 
Table 2. Features of coronavirses, toroviruses, and arteriviruses 
Features Coronaviru Torovir Arterivir 
Virion morphology: 
Presence of envelope 
Nucleocapsid symmetry 
M protein with triple membrane-spanning 
Presence of prominent spikes 
Presence of coiled-coil structure in spikes 
Genome size (kb) 
Genome organization3 : 
Linear positive-sense ssRNA with poly (A) tail3 
5' polymerase gene-structural protein genes 3' 
5' leader sequence 
Gene expression: 
3' co-terminal nested set of > 4 subgenomic mRNAs3 
Only 5' unique region of mRNAs is translationally active1 
Ribosomal frameshifting in the polymerase gene 
Intracellular budding 
Size of virion proteins (kDa): 
Large surface glycoprotein (S or G) 
Hemagglutinin esterase protein (HE) 
Integral membrane protein (M) 
Small membrane protein (E or sM) 
Nucleocapsid protein 
+ 
helical 
-k 
+ 
+ 
27-31 
+ 
+ 
+ 
+ 
+ 
+ 
180-220 
60-65" 
25-35 
10-12 
43-50 
+ 
tubular 
+ 
4. 
+ 
-25 
200 
26 
d 
18 
isometric 
+ 
13-15 
+ 
+ 
+ 
Gl 25-50 
Gs 25-35 
C 
18-19 
_d 
12-15 
(modified from Cavanagh, 1997) 
3 Primary common characteristics for inclusion of viruses in the order Nidoviridae 
b Present in only a subset of coronaviruses 
c HE pseudogene known for Berne virus 
d No such protein described 
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genes, 3'-NCR, and the polyadenylated tail (Allende et al.. 1999; de Vries et al., 1997; 
den Boon et al., 1991; Godeny et al., 1993; Meulengberg et al., 1993a; Nelsen et al., 
1999; Snijder and Meulenberg, 1998). The 5' and 3' NCRs are 156 to 220 and 59 to 117 
bases, respectively. The non-structural genes, i.e., the overlapping open reading frames 
(ORFs) la and lb, constitute about 80 percent of the viral genome and encode RNA 
polymerase and other critical enzymes required for RNA genome replication and 
transcription (Allende et al., 1999; den Boon et al., 1991; Meulengberg et al., 1993b; 
Nelsen et al., 1999). The structural genes of arteriviruses consist of at least 6 overlapped 
ORFs for PRRSV, LDV, and EAV and 9 for SHFV (Allende et al.. 1999; den Boon et al., 
1991; Meulengberg et al., 1993a; Nelsen et al., 1999; Smith et al., 1997; Wang et al., 
1998). In SHFV, ORFs 2a, 2b, 3,7.8, and 9 correspond to ORFs 2, 3,4, 5, 6, and 7 of 
the other arteriviruses. ORFs 4, 5, and 6 of SHFV show a high degree of genetic 
homology to ORFs 2a, 2b, and 3 of its own genome and are considered to be the result of 
recombination events during SHFV evolution (Godeny et al., 1998). In EAV, an 
additional conserved ORF between the 3' end of ORF lb and ORF 2 has been identified 
and designated as ORF 2a (Snijder et al., 1999). As a consequence, the previous ORF 2 
has been renamed ORF 2b. This bicistronic ORF 2 pattern was also found in a Canadian 
PRRSV isolate and designated ORFs 2a and 2b (Wootton et al., 2000). Although ORFs 
2a and 2b in EAV and PRRSV are located in nearly corresponding regions of the 
genome, the size of the genes and the functional roles of these gene products may not be 
the same. In EAV, ORFs 2a and 2b encode proteins E and G$, which are essential for the 
production of infectious progeny virus (Snijder et al., 1999), but the functional role of 
PRRSV ORFs 2a and 2b products is not known at present. 
Replication of arteriviruses 
Entry and uncoating 
Arteriviruses typically replicate preferentially in cells of the monocyte-
macrophage lineage in vivo and in vitro (Chan et al., 1989; Crawford and Henson, 1972; 
Gravell et al., 1980; Wensvoort et al., 1991). In addition, testicular germ cells and 
neuron cells have also been shown to support replication of PRRSV and LDV-C, 
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respectively (Contag et al., 1986, 1989; Sur et al., 1997). In vitro, PRRSV is known to 
replicate in limited number of established continuous cell lines, including the African 
green monkey (Cercopithecus aethiops) kidney cell line MA-104 and its highly 
permissive clone MARC-145, the proprietary cell lines CL2621 and ATCC CRL11171 
(Benfield et al., 1992; Kim et al., 1993; Meng et al., 1996). Like PRRSV, SHFV also 
replicates in the MA-104 cell line. For its part, EAV replicates in a variety of cell lines, 
including baby hamster kidney (BHK-21), rabbit kidney (RK-13), African green monkey 
kidney (Vera), fetal equine kidney (HK), and equine dermis (NBL-6) cell (Hyllseth, 
1969; Konishi et al., 1975; McCollum et al., 1986). In contrast, no cell line has been 
discovered that can support LDV replication in vitro (Plagmann and Moennig, 1992). 
Arteriviral infection begins with the attachment of the virus to the target cell. A 
210 kD membrane protein on the surface of porcine alveolar macrophages has been 
identified as the putative receptor for PRRSV (Duan et al., 1998). In MARC-145 cells, a 
heparin-like molecule has been reported to play the same role as the 210 kD macrophage 
membrane protein (Jusa et al., 1997). LDV may use the same pathway as PRRSV for 
entry into the macrophage (Kowaichy and Plagemann, 1985). For LDV, it was suggested 
that the major histocompatibility complex (MHC) class II la antigen was the receptor for 
virus binding (Inada and Mims, 1985). However, this premise was not supported by the 
observation that trypsine treatment of macrophages abolished the binding process, but 
only partial affected this molecule (Buxton et al., 1988). Thus, further studies are needed 
to determine whether all arteriviruses use similar receptors. Following attachment, entry 
occurs via receptor-mediated endocytosis that moves the virion into the cells within a 
vesicles through a clathrin-dependent pathway (Nauwynck et al., 1999). During virus 
internalization, low pH in the intracellular compartment is required for PRRSV uncoating 
(Kreutz and Ackerman, 1996; Nauwynck et al., 1999). 
Genome replication and expression 
Once within the cell, gene replication and expression occur in the cytoplasm. 
Genomic replication and expression involves the reproduction of full-length genomic 
RNA and the transcription of a set of 6 to 9 smaller subgenomic mRNAs. This process is 
10 
particularly well-described for EAV (den Boon et al., 1991; Snijder and Meulenberg, 
1998; Ziebuhr et al., 2000). The process begins with the expression of genomic RNA 
(positive sense) from which ORFs la and lab (proteinases and replicase) are translated, 
the latter by a frameshift mechanism (den Boon et al., 1991). A total of 12 final products 
and many intermediates are generated via a series of cleaving process on these two 
polypeptides (Snijder and Meulenberg, 1998; Ziebuhr et al., 2000). The EAV replicase is 
the only enzyme required for EAV genome replication and transcription of subgenomic 
mRNA (Molenkamp et al., 2000a). The conserved frameshift region located between the 
ORF la and lb is also required for efficient replication of full-size genome replication 
(Molenkamp et al., 2000b). A set of subgenomic mRNAs is produced by a mechanism of 
discontinuous transcription by which the common leader sequence at the 5'end and 
mRNAs of varying size at the 3' end of the genome are combined. This conjunction is 
located at a short, conserved sequence element, the transcription-regulating sequence 
(TRS), which appears at the 3' end of the leader sequence and 5' end of the body (van 
Marie et al., 1999). As a result, the genomic RNA and all of the subgenomic mRNAs 
share a common leader sequence at the 5' end and NCR at the 3'end. 
Viral proteins 
Arteriviral structural proteins are expressed from this 3' co-terminal nested set of 
6 to 9 subgenomic mRNAs (den Boon et al., 1991; Godeny et al., 1993; Meulengberg et 
al., 1993a; Nelsen et al., 1999; Palmer et al., 1995). Only the gene at the most 5' end can 
be expressed. Using PRRS-LV terminology, PRRS viral proteins encoded by ORF 2 to 7 
are GP (glycoprotein) 2, 3,4, 5 (envelope, E), M (matrix), and N (nucleocapsid) proteins 
with molecular masses of 29 to 30,45 to 50,31 to 35,25, 19, and 15kD, respectively 
(Conzelmann et al., 1993; Mardassi et al., 1995; Meng et al., 1994; Meulengberg et al., 
1995.1997). The M and N proteins are not glycosylated and GPs 2 to 5 are believed to 
be associated with the envelope. All of those proteins have been identified in PRRS-LV 
using polyvalent porcine anti-LV serum, gene-specific anti-peptide sera or monoclonal 
antibodies. However, only 5 viral proteins (GP3, GP4, GP5, M, N) have been 
demonstrated in PRRS-VR-2332 or infected cell lysates (Bautista et al.. 1996; Benfield et 
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al., 1992; Mardassi et al., 1994,1996, Meulenberg et al. 1995). Likewise, only 4 proteins 
[(GP2 (GS), GP5 (Gl), M, N)] have been identified in EAV, 3 [(GP5 (VP3), M, N)] in 
LDV. and 2 (M, N) in SHFV (de Vries et al., 1992; Faaberg and Plagemann, 1995; 
Snijder and Meulenberg, 1998). 
Among the viral proteins, N, M. and GP5 are the most abundant in infected cells 
and in whole virions, and contain 90 to 95 percent of structural proteins of arteriviral 
particles (Snijder and Meulenberg, 1998). The N protein is highly immunogenic and has 
been considered the best antigen for diagnostic use in PRRSV and EAV infection (de 
Vries et al., 1992; Dea et al.. 2000a, b; Mardassi et al., 1994, 1996; Yoon et al 1995). 
The residues of the M protein span the viral membrane at least three times. The part of 
its N-terminus exposed on the viral surface is linked to the ectodomain of GP5 by a 
disulfide bond (de Vries et al., 1995; Faaberg et al., 1995b; Mardassi et al.. 1996). This 
linking by a disulfide bond has proved to be essential for LDV inactivity (Fabberg et al.. 
1995b). The GP5 of PRRSV, LDV, and EAV primarily induce neutralizing antibody 
(Cafruny et al., 1986; Chimside et al., 1995a, b; Tobiasch et al., 2001 ; Pirzadeh and Dea, 
1997; Yang et al., 2000; Yoon et al., 1995). In PRRSV, GP5 is also believed to play a 
role in apoptosis of infected MA-104 cells, CR11171 cells, and macrophages in vitro 
and/or in vivo (Sirinarumitr et al., 1998; Suarez et al.. 1996; Sur et al., 1998, 2001). 
In EAV, both the ORF 2b and the small ORF 2a proteins are required for the 
production of infectious progeny virus (Snijder et al., 1999), but the functional role of the 
recently reported bicistronic ORF 2 of PRRSV remains to be determined (Wootton et al.. 
2000). The GP3 protein is believed to be soluble or only partly incorporated into the 
PRRS virion (Mardassi, et al., 1998). The PRRSV GP4 also have been reported to 
induce neutralizing antibodies (Le Gall et al., 1997; Meulenberg et al., 1997; van 
Nieuwstadt et al., 1996;Weiland et al., 1999; Wieczorek-Krohmer et al., 1996). 
Assembly and release 
A distinctive double-membraned vesicle, visible electromicroscopically in the 
perinuclear regions of the cell, has been reported in PRRSV-infected porcine lung 
alveolar macrophages (Pol, and Wagenaar, 1992; Pol et al., 1997), EAV infected RK-13 
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cells (van Dinten et al., 1996), SHFV infected macrophages (Wood et al.. 1970), and 
LDV infected macrophages (Stueckemann et al., 1982). Furthermore, using gene-
specific monoclonal antibodies, products of EAV replicase subunits have been detected 
on the pericular region and intracellular membrane (van Dinten et al., 1996; van der Meer 
et al., 1998). It is still unclear whether this generative structure linked with viral RNA 
synthesis and assembly. In addition, the products of PRRSV ORFs 5,6. and 7 have been 
demonstrated mainly in the perinuclear and endoplasmic reticulum (ER), perinuclear 
areas and Golgi apparatus, and cytoplasm and nucleolus, respectively (Dea et al., 1995; 
Mardassi et al., 1994, 1996; Pol and Wagenaar, 1992; Pol et al., 1997). 
As all of known components required for virion assembly located in the areas 
described above, the assembly of arteriviruses are completed by preformed nucleocapsid 
gaining an envelop through budding from the membrance of smooth endoplasmic 
reticulum and/or the Golgi apparatus (Pol and Wagenaar. 1992; Stueckemann et al.. 
1982; Wada et al., 1995; Wood et al, 1970). The virions are believed to be release by 
exocytosis. 
Progeny PRRSV RNA can be detected as early as 6 hours post inoculation (Dea et 
al., 1995; Pol et al.. 1997). and complete virions by 9 to 12 hours post inoculation in 
infected porcine alveolar macrophages (Pol and Wagenaar, 1992; Pol et al.. 1997). The 
LDV and EAV viral RNA and virions could be detected by 12 to 24 hours (Magnusson et 
al., 1970; Stueckemann et al., 1982). 
Conservation of non-structural genes 
The incessant evolution of RNA viruses occurs in an environment pitting genetic 
mutation against environmental selection. Regardless of any other possible advantage 
conferred by a genetic change, the replicative functionality of the virus must be 
maintained. Thus, among arteriviruses, ORF 1, responsible for RNA polymerase and 
related functional motifs, is more conserved and the genes encoding proteins exposed on 
the viral surface are more variable (Allende et al., 1999; Chen et al., 1994; Chen and 
Plagemann, 1995; den Boon et al., 1996; Faaberg et al., 1998; Godeny et al., 1993, 1998; 
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Meulenberg et al, 1993b; Oleksiewicz et al., 1999; Palmer et al., 1995). The following 
provides more specific examples. 
The 5' NCR contains most of the 5' leader sequence and includes a leader-body 
junction sequence crucial for genomic expression of arteriviruses (Chen et al., 1993; den 
Boon et al., 1996; Faaberg et al., 1998; Meulenberg et al, 1993b; Nelsen et al., 1999; 
Pasternak et al., 2000; Zeng et al., 1995). The size of the 5' leader is conserved, i.e., 190 
to 220, 156 to 161,206 to 211, and 208 bases for PRRSV, LDV, EAV and SHFV, 
respectively, but not the sequence (Allende et al., 1999; Chen et al., 1993, 1994; den 
Boon et al., 1991,1996; Godeny et al., 1998; Meulenberg et al., 1993b, 1998; Nelsen et 
al., 1999; Oleksiewicz et al., 1999; van Dinten et al., 1997; Zeng et al., 1995). For 
example, the 5' leader sequence of PRRSV showed only 50 percent nucleotide identity 
between two European and one American isolates (Oleksiewicz et al., 1999). In contrast, 
the leader-body junction sites for binding 5' leader and 3' body genomic and subgenomic 
sequences are conserved among arteriviruses (Chen et al., 1993, 1994; den Boon et al., 
1996; Faaberg et al., 1998; Godeny et al., 1998; Nelsen et al., 1999; Oleksiewicz et al., 
1999; Pasternak et al., 2000; Zeng et al., 1995). The consensus sequences of the leader-
body junction site are 5'-UUAACC-3' for PRRSV and SHFV (Faaberg et al., 1998; 
Godeny et al., 1998; Meulenberg et al, 1993b; Nelsen et al., 1999; Oleksiewicz et al., 
1999: Zeng et al., 1995), 5'-UAUAACC-3' for LDV (Cheng et al., 1993, 1994), and 5'-
UCAAC-3' for EAV (den Boon et al., 1996). 
Although the 5' leader of PRRSV showed only 50 percent nucleotide identity 
between two European and one American isolates (Oleksiewicz et al., 1999), the 5' 
leaders each contained three identical strings of 8,11, and 9 conserved nucleotides at its 
3'end and the junction motif downstream of those. The junction motif, (5'-
U(U/G)AACC-3') involved in viral replication, is conserved (Oleksiewicz et al., 1999). 
Various leader-body junction sequences and sites are involved in producing subgenomic 
mRNAs (Faaberg et ai., 1998; Meulenberg et al, 1993b; Nelsen et al., 1999). For 
example, two alternate leader sequences were used for producing subgenomic mRNA 7 
encoding the nucleocapsid, one (5'-AUAACC-3') located 123 nucleotides and the other 
(5'-UAAACC-3') 9 nucleotides upstream of the AUG start site (Faaberg et al., 1998). 
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The mechanism for selecting alternate junction sequences and sites for different mRNAs 
was also used to other arteriviruses (Chen et al., 1993; den Boon et al., 1996; Pasternak et 
al., 2000; Zeng et al., 1995). 
In addition, it is believed that the position and secondary structure of PRRSV and 
EAV body junction sites may influence the efficiency of genomic replication and 
transcription process and the production of progeny virions (Nelsen et al., 1999; 
Pasternak et al., 2000). However, the functional role of usage of different nucleotides 
within the body junction sequence is still unknown. 
Interestingly, small intraleader ORFs ranged from 35 to 110 nucleotides in size 
have been found upstream of ORF la in PRRS-LV, EAV, and SHFV, but not LDV 
(Kheyar et al., 1996; Meulenberg et al.. 1998; Zeng et al., 1995). A smaller intraleader 
ORF was also found in mouse hepatitis virus, a virus belonging to the family 
Coronaviridae, (Chen and Baric, 1995). At present, the function of this small ORF is 
unknown. 
ORF la is variable in size (1727 to 2396 nucleotides) among arteriviruses and the 
sequence is less conserved (Table 4) than ORF lb (Allende et al., 1999; den Boon et al., 
1991; Godeny et al., 1993; Meulengberg et al., 1993b; Nelsen et al., 1999), but the coding 
regions responsible for specific proteases and their corresponding cleavage sites are 
highly conserved among PRRSV, LDV, and EAV (Allende et al., 1999; den Boon et al., 
1991 ; Godeny et al., 1993; Meulengberg et al., 1993b; Nelsen et al., 1999; Snijder and 
Spaan, 1995). The slippery sequence, 5'-UUUAAAC-3', and a putative pseudoknot 
structure between the ORF la and lb are crucial for the frame-shift translation of ORF 
lab polyprotein and, therefore, highly conserved. In EAV, this polyprotein is later 
cleaved ten times by three ORF la encoding proteases into 12 different non-structural 
proteins (nsp 1-12) (den Boon et al., 1995). Similar putative gene products of the ORF 
lab polyprotein have been demonstrated for PRRSV and LDV (Godeny et al., 1993; 
Meulenberg et al., 1993b; Nelsen et al., 1999). 
ORF lb is most conserved both in sequence (Table 4) and in size (1410 to 1463 
nucleotides) among PRRSV, LDV, and EAV (Allende et al., 1999; Chen and Plagemann. 
1995; den Boon et al., 1991; Godeny et al., 1993; 1995; Meulenberg et al, 1993b; 
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Table 4. Sequence identity of PRRS-VR-2332 ORF 1 to that of other arteriviruses 
Viruses PRRSV(LV) LDV-P EAV 
ORFs % nta % aab % nt % aa % nt % aa 
la 54.7 55.6 51.6 46.7 41.0 28.3 
lb 63.1 75.3 55.4 62.2 47.8 46.6 
(Modified from Nelsen et al., 1999.) 
a nt, nucleotide 
b aa, amino acid 
Wootton et al., 2000). SHFV ORF lb has only been partly sequenced to date, but 
exhibits 50 percent nucleotide homology with corresponding segments of PRRS-LV, 
LDV, and EAV (Chen and Plagemann, 1995). Interestingly, the North American 
prototype PRRS-VR-2332. showed only 75.3 percent amino acid identity to the European 
prototype PRRS-LV in ORF lb gene, versus 62.2 percent amino acid identity to LDV-P 
and 46.6 percent to EAV (Nelsen et al., 1999). This degree of heterology in ORF lb 
between PRRS-VR-2332 and PRRS-LV is intriguing, given that both virus infect the 
same animal species and induce the same disease pattern. 
Variation of structural genes 
Using PRRS-LV as a baseline, the sequence comparison of structural genes 
among arteriviruses is summarized in Table 5. ORFs 2a to 6 and 7 to 9 of SHFV were 
compared to ORFs 2 to 4 and 5 to 7 of PRRS-LV (Godeny et al., 1995; Smith et al., 
1997). Compared to PRRS-LV, ORF 6 (matrix) and 7 (nucleocapsid) proteins are more 
conserved than other ORFs among PRRSV, LDV, and SHFV. Although ORF 5 (major 
envelope protein) is less conserved than ORFs 6 and 7. it is more conserved than ORFs 2 
to 4 (GPs 2 to 4) among PRRSV, LDV and SHFV (Dea et al., 2000a; Godeny et al., 
1995; Meulenberg et al.. 1997; Smith et al., 1997; Snijder and Meulenberg, 1998). In 
general, PRRSV, LDV, and SHFV are genetically and evolutionarily closer to each other 
than to EAV, based on the sequences of structural genes. 
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Table 5. Comparison of ORF 2 to 7 encoding amino acid of PRRS-LV to those of 
other arteriviruses 
ORFs PRRSV-10* VR-2332" VR-2385' IAF-Klopd LDV-P' LDV-Cf EAV8 SHFVh 
2 99 63 62 59 38 32 NS' 39-49" 
3 99 60 57 54 31 28 NS 39-49 
4 99 70 69 68 29 30 NS 39-49 
5 99 55 54 52 47 47 NS 57 
6 100 79 78 81 53 53 23 57 
7 100 64 57 59 41 44 20 41 
(Modified from Dea et al., 2000 and Meulenberg et al., 1997) 
* Conzelmann et al.(1993) 
b Murtaugh et al. (1995) 
c Meng et al. (1994) 
d Mardassi et al. (1995) 
'Chenet al. (1994) 
r Godeny et al. (1993) 
8 den Boon et al. (1991) 
h Godeny et al. (1995); Smith et al. (1997) 
1 NS, not significant (<20%) 
' Sequence compared between 2a-6 of SHFV and 2-4 of PRRS-LV, Smith et al. (1997) 
Among PRRSV isolates. European PRRS-LV showed 99 to 100 percent amino 
acid homology of the structural genes to those of another European isolate PRRSV-10, 
but only 63. 60, 70, 55, 79, and 60 percent identity to ORFs 2 to 7 of North American 
PRRS-VR-2332, respectively (Conzelmann et al., 1993, Meulenberg et al., 1998; 
Murtaugh et al., 1995). Among European and North American PRRSV isolates, ORF 6 
has frequently been reported to be the most conserved, and ORF 5 the most diverse, of 
the structural genes (Andreyev et al., 1997; Kapur et al., 1996; Mardassi et al., 1995; 
Meng et al., 1994, 1995; Morozov et al., 1995). 
Genetic diversity due to differences in the geographic origin of isolates has also 
been observed among EAV isolates. Based on the ORF5 gene (GL protein), 43 field 
isolates collected during 40 years from Europe and North America were phylogenetically 
separated into two large groups and five subgroups (Stadejek et al., 1999). Most North 
American isolates constituted one group and European isolates the other. This study also 
found that the Gl gene of EAV may be a useful tool for tracing routes by which EAV is 
spread (Stadejek et al., 1999). 
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It is worth noting that ORF 5 is the most diverse gene among PRRSV isolates, 
even though it is the most conserved structural gene among arteriviruses. This 
dichotomous observation may reflect the fact that the envelope protein plays a crucial 
role in virus-cell receptor binding, but is also the primary target of the host's neutralizing 
antibody. Thus, both the virus and the host are involved in gene conservation and 
diversification in the on-going evolution of arteriviruses. 
Antigenic variation 
The antigenic variation of arteriviruses is a reflection of their genetic variation. 
Unfortunately, the majority of the studies have been done in PRRSV and little has been 
reported for the LDV, EAV, and SHFV at this point in time. Broad antigenic variation 
has been demonstrated between European and North America PRRSV field isolates. 
Using an immunoperoxidase monolayer assay (IPMA), Wensvoort et al. (1992) evaluated 
the reactivity of polyclonal porcine antibodies raised against either PRRS-LV or PRRS-
VR-2332 with PRRS virus isolates from around the world. The investigators were able 
to differentiate European from North American isolates on the basis of differences in 
IPMA antibody titers. That is, significantly higher antibody titers were obtained in the 
homologous assay system. Later studies found even greater antigenic diversity among 
PRRS virus isolates than initially suspected (Bautista et al., 1993; Dea et al., 1996; Drew 
et al.. 1995; Frey et al., 1992; Yoon et al., 1995). Yoon et al. (1995) examined 22 PRRS 
virus isolates from 8 different U.S. states recovered from samples collected between 1989 
and 1993. Using a panel of 5 monoclonal antibodies (Mabs) specific for the N protein, 
the 22 virus isolates fell into one of 3 groups based on their reactivity pattern. 
Subsequently, Yang et al. (1999) expanded this study to include 70 North American 
isolates recovered from samples collected between 1989 and 1995 using a panel of 23 
Mabs against the N protein. These investigators found 5 antigenic groups, with the 
European Lelystad virus representing an antigenic group distinct from any of the North 
American groups identified. Subsequently, using antibodies against discontinuous 
epitopes of the N and M proteins and continuous epitopes of the E and GP3 proteins, the 
65 North American isolates in the first and second antigenic groups were further 
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subdivided into 9 and 4 antigenic subgroups, respectively (Yang et al., 2000). Broad 
antigenic variation based on other PRRSV structural proteins, especially for GP5 
proteins, has been reported by many investigators and reviewed by Dea et al. (2000a), 
Meng (2000), Yang (2000) and Zimmerman et al. (1998). 
RNA Virus Evolution 
Unlike DNA polymerase, the viral RNA-dependent, RNA polymerase and/or 
reverse transcriptase lack proof-reading, repair, and/or post replicative error correction 
mechanisms to fix mistakes that occur during the replication process (Bakhanashvili and 
Hizi, 1992; Hubner et al., 1992; Ward et al., 1988). The error-prone nature of RNA 
polymerase results in a high mutation rate and rather than exact copies of the parent, the 
progeny population is a 'quasispecies.' 
Quasispecies 
A "quasispecies" is defined as a virus population composed of a spectrum of 
mutants (Domingo et al., 1996). One subpopulation of variants may be dominant within 
the population, but many different but related subpopulations exist simultaneously 
(Doming et al., 1996). This concept was originally postulated by Eigen and Schuster in 
1979 to describe the early replicon on earth and has been adapted to studying RNA virus 
populations at the molecular level (Domingo et al., 1996; Holland, et al., 1992;). More 
recently, the concept of quasispecies has become the basis for addressing the issues of 
RNA virus evolution pertaining to viral persistence and pathogenesis, emergence of new 
diseases, attenuation of vaccine virus strain, the relationship between genetic bottlenecks 
and viral fitness, and even applied to other concepts, such as Muller's ratchet, the 
competitive exclusion principle, and the Red Queen hypothesis (Domingo, 1997; 
Domingo et al., 1996,1998; Domingo and Holland, 1997; Duarte et al., 1994; Mcknight 
et al., 1995; Weaver, 1998). Given the wide genetic and antigenic variation known to 
exist among field isolates, particularly in the case of PRRSV and EAV, it is natural to 
consider arteriviruses from the perspective of viral quasispeces. 
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Mechanisms for the variability of RNA viruses 
Mutation and recombination are the two primary mechanisms involved in RNA 
virus evolution (Domingo, 1997; Domingo et al., 1996; Nagy and Simon. 1997). 
Reassortment may be considered as an alternate of recombination for segmented viruses, 
i.e., the rotaviruses and influenza viruses (Gombold and Ramig, 1994; Webster et al, 
1995). 
Mutation 
The accumulation of point mutations is the most common mechanism driving 
genetic diversity and antigenic variability. Under in vitro conditions, the mutation rate of 
a viral genome during replication can be estimated as mutations/site/replication (or a 
defined number of replications) or, in a longitudinal observational study, as 
mutations/site/year. Due to the absence of proof-reading mechanism in RNA-dependent 
RNA polymerase, the mutation rate of RNA replication is much higher than that of DNA 
replication by as much as a million-fold difference (Gojobori and Yokoyama, 1985). 
Although different genes in an RNA genome may reveal different mutation rates, the 
average mutation rate of an RNA genome was estimated at 10*3 to 10"6 
mutations/site/replication (Drake, 1993; Hubner et al., 1992; Steinhauer and Holland, 
1987; Well et al.. 2001). In comparison, the mutational rate of the DNA genome was 
estimated at 10"7 to 10*" mutations/site/replication (Beckman and Loeb, 1993; Calcagnile 
et al., 1996; Drake, 1991; Holland et al., 1982;). In observational studies, the mutation 
rate of nucleotides in the NS gene of influenza A viruses collected from 15 humans over 
a period of 53 years showed 2 changes every 1000 nucleotides per year in a uniform and 
steady pace over the years (Buonagurio et al., 1986). Investigators concluded that it was 
a good molecular clock and compatible with the hypothesis that positive selection is 
operating on the hemagglutinin (or perhaps some other viral genes) to preserve random 
mutations in the NS gene. 
In common with other RNA viruses, mutations appear to be introduced into the 
arterivirus genome during viral replication (Beckman and Loeb, 1993; Fry and Loeb, 
1986; Joyce and Steitz, 1994; Meulenberg et al., 1993a, b; Nelsen et al.. 1999; Steinhauer 
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et al., 1992). For EAV, a longitudinal study compared the structural genes (ORFs 2 to 7) 
of virus recovered from semen samples collected from two infected stallion with long-
term persistence for periods of 11 and 5 years, respectively (Hedges et al., 1999). 
Investigators found that EAV evolved continuously over time and independently in each 
animal. The mean estimated mutation rates were 9 and 13 bases every 1000 nucleotide 
per year respectively in those two infected animals. Genetic change associated with 
mutation over time has not been reported for PRRSV, LDV, and SHFV. 
Recombination 
By definition, recombination involves the direct exchange of genomic segments 
between two parental viruses, thereby producing a progeny with a different genotype. 
Recombination is perhaps the most effective mechanism available to viruses for 
generating diversity. Through recombination, RNA viruses are able to exchange genetic 
information between either homologous or non-homologous viral counterparts. It 
follows that genotypic diversity can develop rapidly within a virus population, thereby 
expanding its capacity to adapt to the environment. Due to the absence of repair 
mechanisms possessed by DNA viruses, RNA viruses may also use recombination to 
repair genetic defects (Lai, 1996). However, recombination also has potentially adverse 
effects and may produce non-functional recombinants and defective interfering (DI) 
viruses (Lai, 1992). 
Nagy and Simon (1997) have proposed a new classification system for 
recombination which consists of three classes: similarity-essential (Class 1), similar!ty-
nonessential (Class 2), and similarity-assisted (Class 3) recombination. A high degree of 
sequence homology between the parental RNAs is required for Class 1 recombination. It 
follows that Class 1 recombination, perhaps between identical parental RNAs, may occur 
without significant mutation. Class 2 recombination does not require a high degree of 
sequence homology at the crossover site between parental RNAs; however, the degree of 
homology for base pairing at the crossover site may affect the efficiency of 
recombination. Instead of the high level of sequence homology required for class 1 
recombination, the secondary structure of the crossover site may play the critical role in 
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this event. Class 3, the similarity-assisted recombination combines the features of 
Classes 1 and 2. Both sequence homology and secondary structure of the crossover site 
are critical for Class 3 recombination event. Thus, recombination in conclusion, any 
particular mechanism can not describe the variety of recombination events for all virus 
system. 
Recombination has been documented to occur in all arteriviruses both during 
replication in cell culture and in the host. In PRRSV, Kapur et al. (1996) analyzed the 
ORF 2 to 7 genes of 10 isolates obtained from swine operations in the Midwestern United 
States during the period of 1989 to 1992 and found that intragenic recombination events 
had occurred in ORF 2, 3,4. 5 and 7, but not ORF 6. The investigators speculated that 
ORF 6 recombinants underwent negative selection. Yuan et al. (1999) reported that the 
5' end of PRRSV ORF5 was a target site for the crossover of recombination. 
Recombination between two PRRS viruses has also been demonstrated in vitro. Yuan et 
al. (1999) co-infected MA-104 cells with two different cell culture-adapted vaccine 
viruses, RespPRRS® and Prime Pac® PRRS, and detected recombinants containing 
chimeric ORF 3 and 4 sequences. The recombinants could evolve and compete with 
parental viruses for at least three cell culture passages. Analysis of 1182 nucleotides 
bases of cloned recombinants encompassing the ORF 3,4, and part of ORF 5, found six 
independent recombination events with estimated recombination rates ranging from 2 to 
10 percent in the 1182 bases examined. The mechanism of PRRS viral recombination 
was determined to be the Class 1 recombination as described previously (Nagy and 
Simon, 1997). 
LDV showed a high frequency of homologous genetic recombination in mice 
experimentally infected with high dose of a neuropathogenic strain (LDV-C) and a non-
neuropathogenic strain (LDV-P) (Li et al., 1999). The ratio of LDV-P/C and C/P 
recombinants varied. A new neuropathogenic recombinant (LDV-v) was found to be a 
natural recombinant of another new non-neuropathogenic strain (LDV-vx) that acquired 
about 400 nucleotides of the 5'end of ORF 5 of LDV-C by a double recombination. The 
recombination rate was about 5 percent in a sequence (1276 nucleotides) encompassing 
ORFs 5, 6, and 7 after one day of replication in mice. Also, during this dual infection, 
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the LDV-C quasispecies disappeared, while LDV-P persisted along with the new 
recombinant LDV-vx in a stable evolutionary relationship (Li et al., 1999). The loss of 
LDV-C quasispecies was considered to be the result of the intrinsic replication 
disadvantage of their genomes, not due to greater susceptibility to neutralizing antibody 
(Li et al., 1999). Recombination events mostly occurred at stretches (26 to 43 
nucleotides) of high degree of sequence homology between LDV-P and LDV-C, i.e., 
similar to the Class 1 recombination. 
Recombination events in EAV were studied using an EAV defective interfering 
(EDI) RNA consisting of three 5' noncontiguous parts of the EAV genome fused in a 
frame with respect to the replicase gene of EDI RNA (Molenkamp et al., 2000b). Using 
recombination assays based on this EDI RNA and the help virus genome, a full-length 
EAV containing specific mutations, the author found that the homologous recombination 
rate in the 5'-end was 100-fbId lower than that in the proximal 3'-end, i.e.. in the ORF lb 
region. Although the mechanism is uncertain, a similar phenomenon had been previously 
reported in murine hepatitis virus (MHV), a virus in the family Coronaviridae (Fu and 
Baric, 1992; 1994). The MHV had shown a recombination rate three times higher of in 
the spike protein gene than that in the replicase gene (Fu and Baric, 1992). This variable 
recombination rate in different genes of coronaviruses may be related to a discontinuous 
subgenomic transcription mechanism (Baric, et al., 1990; Keck et al., 1987; Lai, 1996). 
SHFV contains three more ORFs than other arteriviruses, a fact that has been 
showne to be the result of a recombination event (Godeny et al., 1998). Sequence 
analysis of the 3' end of SHFV found that ORFs 2a, 2b, and 3 are the counterparts of 
ORFs 4, 5, and 6 of other arteriviruses. It has been speculated that ORFs 4 to 6 may have 
been acquired from a distantly related arteri virus as a consequence of a heterologous 
recombination event. Presumably, progeny virus with this genomic duplication 
possessed a competitive advantage relative to parental strains of SHFV in the population. 
RNA virus evolution in populations 
The concepts of "Muller's ratchet", the competitive exclusion principle, and the 
Red Queen hypothesis were originally used in classical studies on the evolution of higher 
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organisms and were only later applied to the RNA world (Ayala, 1971; Clarke et al., 
1994; Domingo et al., 1996; Duarte et al., 1992; van Valen, 1973). 
Muller 's ratchet 
Muller's ratchet postulates that the 'fitness' of a population declines over time as 
individuals without deleterious mutations become scarcer. In virology, 'fitness' is 
defined as the ability to replicate. Many studies have examined the mean fitness of a 
viral subpopulation through a series of in vitro bottleneck transmissions (Clarke et al., 
1993; Duarte et al., 1992, 1994; Elena et al.. 1996; Novella et al., 1999). The effect of 
Muller's ratchet is particularly evident during the process of a plaque-to-plaque passage 
in the cell culture (Duarte et al., 1992). Duarte el al. (1992) followed vesicular stomatitis 
virus (VSV) through 20 passages and evaluated relative fitness using BHK-21 and HeLa 
cells. Variable loss in fitness was observed in most clones, although some showed no 
fitness change. The decline in fitness was due to mutations or accumulation of mutations 
in the purified viral population that resulted in the lack of the viral genetic capacity to 
replicate efficiently in the cell population. Theoretically, fitness could be regained by 
repairing disastrous mutations with the help of other viruses, either through 
recombination or through massive population passage (Novella et al., 1995). In vivo, 
Muller's ratchet could lead to attenuation of viral virulence during rapid evolution in 
hosts (Bergstrom et al., 1999). Analytical and simulation studies suggest that severe 
bottlenecks are most likely to decrease the virulence of a pathogen due to the stochastic 
loss of the most virulent pathotypes (Bergstrom et al., 1999). However, the actual effects 
of bottleneck still remain largely undocumented at the host level. 
Competitive exclusion principle 
In population genetics, the competitive exclusion principle states that one species 
will always outcompete another if both occupy the same niche (Domingo et al., 1996). 
An in vitro study by Clark et al. (1994) is a virological example of the competitive 
exclusion principle. Two vesicular stomatitis virus (VSV) clones with almost the same 
degree of fitness were mixed together and passaged on BHK-21 cells. Ultimately, one 
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clone outcompeted the other. Similarly, Chen et al. (1998a) reported that, in a mixed 
infection of neuropathogenic (LDV-C) and non-neuropathogenic (LDV-P) strains, the 
LDV-P strain ultimately outcompeted the LDV-C strain resulting in mice persistently 
infected with LDV-P. 
The Red Oueen hypothesis 
The Red Queen hypothesis is taken from the well-known book, Through the 
Looking Glass written by Lewis Carroll (1832 - 1898). In the story, the Red Queen tells 
Alice that she must keep running simply to stay in place on the ever-shifting chessboard. 
In the same way, the Red Queen hypothesis maintains that organisms must keep evolving 
just to maintain their existance in an ever-shifting environment. In the world of microbial 
evolution, the Red Queen hypothesis describes the relationship between competitors in a 
defined environment (van Valen, 1973. Domingo et al., 1996). The hypothesis is that 
each competitor is competing with the others in a zero sum game for the same resource. 
That is. there can be no absolute winner and no loser because neither can completely 
outcompete the other. This concept may apply to the viral evolution in the field 
population, but more studies are needed to test and apply the hypothesis at the host level. 
Biological Implications of Virus Evolution 
Understanding the existence and ever-evolving nature of viral quasispecies has 
provided us the means to explain many of our biological observations (Domingo, 1997). 
For example, the reversion to virulence of an attenuated vaccine virus due to appearance 
of a more fit, but virulent, variant. For the same reason, we can anticipate the fact that, 
because of ongoing virus evolution, the continuous appearance of new virus variants will 
present problems to diagnostic accuracy and challenge the design of effective vaccines. 
RNA virus evolution is a dynamic process between the virus and its host. Within the 
context of constant evolution, we are faced with the fact that any change in either of these 
two principals may disrupt the balance of equilibrium (Kilboume, 1994), as we will 
discuss in the following sections. 
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Virus persistence 
As described previously, all arteriviruses produce persistent infection in hosts 
species. Given the previous discussion on populations, we can assume that viral 
persistence is the result of competition between the virus and the host (Kilboume, 1991, 
1994). Following infection, RNA viruses quickly produce as many as 1010 to 1012 
progeny virions in the host (Wain-Hobson, 1994). Over the course of infection, virus 
replication generates variants with a dynamic distribution, among which are some 
variants highly adapted to the cell population in the host (Eigen and Biebricher, 1988). 
Through competition among virus quasispecies and positive and/or negative 
environmental pressures, the final viral survivors may demonstrate replicative advantages 
and improved adaptability to the host. 
For example, the non-neuropathogenic LDV-P strain was shown to have 
replicative advantages and increased biological resistance to the neutralizing antibody 
compared to the neuropathogenic strain, LDV-C, to the extent that infection of mice was 
lifelong (Chen et al., 1998a, b). For PRRSV, viral persistence in infected pigs has been 
linked with genetic and antigenic profiles. Rowland et al. (1999) found a new PRRSV 
ORF 5 subpopulation in infected pigs from birth to 132 days of age. The infected pigs 
had been exposed to PRRS-VR-2332 in utero. A single nucleotide change had resulted 
in an amino acid substitution at residue 34 [aspartic acid (D) to asparagine (N)]. Le Gall 
et al. (1997) had also found a GP3 epitopic mutant between an isolate and its progeny 
recovered after one or two passages in vivo. In each case, it is speculated that the mutant 
outcompeted the parent virus because it had acquired a more efficient virus-host cell 
receptor binding mechanisms. 
New patterns of viral disease 
From a wider perspective, virus variants have the potential to differ from the 
parent in virulence, tissue tropism, ability to persist in the host, and/or adaptation to new 
hosts (Boyd et al., 1993; Faaberg et al., 1995a; Jarousse et al., 1994; Kilboume, 1994; 
Seif et al., 1985; Subbarao et al., 1993). The cause of a new disease pattern is usually the 
result of a mutated variant rather than a completely new virus (Morse, 1993). A few 
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point mutations in the viral genome may be sufficient to disrupt the balance of viral 
quasispecies in the host population, and propagate disease outbreaks and/or changes in 
the disease pattern (Morse. 1993; Murphy and Nathanson, 1994; Weaver. 1998). For 
example, a few mutations in avian influenza virus produced a highly virulent strain and 
resulted in severe outbreaks in Pennsylvania in 1983 (Kawaoka and Webster, 1985; 
Webster et al., 1986). 
A new disease caused by a completely new virus is not common, but PRRSV 
appears to be one instance in which this occurred (Benfield et al., 1992; Collins et al., 
1992; Wensvoort et al.. 1991). Although an LDV-like virus is considered to be the 
ancestor of PRRS virus, we still do not have the information to explain the concurrent 
appearance of two diverse virus strains, PRRS-LV, and PRRS-VR-2332 on two 
continents. 
Virulent reversion of vaccine virus 
The practical benefit of mutational changes has been seen in the production of 
effective modified-live vaccines, for example the attenuated poliovirus vaccine 
(Bouchard et al., 1995). The ultimate vaccine should be able to produce both protective 
humoral and cellular immunity against the challenge of heterogenous diverse variants. It 
follows that a good candidate for vaccine, derived using either the traditional attenuation 
method or modern site-directed design, must possess the immunologic epitopic domains 
conserved among most of viral variants. However, because of selection within the host 
from the pool of continuously generating viral quasispecies, reversion of vaccine virus to 
virulence is always a concern. Once a virulent variant has been self-selected, an outbreak 
of disease may be the result of vaccination. Thus, stability and safety of vaccine virus 
strains in the host is of great concern. 
Outbreaks of PRRS. either directly or indirectly due to virulent reversion of 
modified-live vaccine virus, have been discussed (Botner et al., 1997; Mengeling et al., 
1998; Rossow et al., 1999). The outbreak of PRRS in Demark in 1996 may be one 
example of the virulent reversion of vaccine-derived virus (Botner et al., 1997; Madsen et 
al., 1998; Storgaard et al., 1999). Sequence analysis of the structural genes of PRRSV 
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isolates collected from infected pigs showed a high degree of sequence homology (99.0 
to 99.5%) to vaccine virus (Madsen et al., 1998). Phylogenetic analysis further suggested 
that the field isolates were more closely related to vaccine virus than to other North 
American field isolates, giving further support to the hypothesis that the outbreak was 
due to the spread of vaccine virus. Reversion to virulence will continue to be a serious 
concern for modified live vaccines used in the control of PRRS. 
Although attenuated vaccine of EAV has been used in the field, prevention of 
EAV is largely dependent on controlling the spread of EAV infection from virus-
shedding stallions (Glaser et al., 1997; Patton et al., 1999). No significant outbreak of 
EAV due to the virulent reversion of vaccine has been reported. However, an avirulent 
variant (CA95G) of EAV isolated from the semen of a persistently infected stallion 
previously vaccinated with the attenuated vaccine caused subclinical infection and 
seroconversion in another susceptible stallion (Patton et al., 1999). Genomic analysis 
showed that the structural gene of this isolate was similar to that of virulent field isolates, 
particularly to a strain of EAV isolated from an outbreak of equine viral arteritis in 
Western Canada in 1986. Genetic diversity increased over the course of the infection in 
the stallion, raising questions and concerns regarding both the mechanisms of persistence 
and reversion to virulence (Patton et al., 1999). Little is known about virulent reversion 
in LDV and SHFV. probably because LDV generally causes subclinical infection and 
because of the technical difficulties and ethical concerns of doing SHFV research. 
Conclusions 
Although the majority of mutations produce no clinically meaningful effects 
whatsoever, it is the potential for genetic mutation to disastrously impact the clinical and 
ecological expression of a virus that fuels research on virus evolution. Certainly, the 
appearance of PRRSV in the pig population was a disastrous event in the history of swine 
production and a reminder that not all changes are neutral. 
The constant mutation and recombination of the viral genomes and competitive 
selection of variants occurs in the context of dynamic interaction between the 
quasispecies and their hosts. Given the randomness with which the process takes place, 
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predictions on future genetic changes are of dubious value. Given the current state of 
knowledge, the most reliable prediction we could make is that understanding the 
fundamental mechanisms of mutation, recombination, degrees, and sources of diversity 
of PRRS virus in the larger context of family Arteriviridae will help us understand what 
is happening and provide us the means to devise valid strategies for disease prevention 
and control. 
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STATEMENTS OF THE PROBLEMS 
Porcine reproductive and respiratory syndrome virus field isolates show a 
remarkable degree of genetic and antigenic variability. Understanding the source and 
degree of virus diversity is important because of its potential impact on viral virulence, 
persistence in the host, protective immunity, and even on our ability to diagnose the 
infection. The assumption is that these changes occur during the course of in vivo 
replication in swine and arise, in large part, because of errors that occur during RNA 
replication. However, the degree and rate of mutation of PRRS virus in infected pigs 
over time is not known. The research described in this dissertation was designed to 
address this question. 
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Abstract 
Porcine reproductive and respiratory syndrome (PRRS) viruses are recognized as 
possessing a high degree of genetic and antigenic variability. Viral diversity has led to 
questions regarding the association of virus mutation and persistent infection in the host 
and raised concerns vis-à-vis protective immunity, the ability of diagnostic assays to 
detect novel variants, and the possible emergence of virulent strains. The purpose of this 
study was to describe on-going changes in PRRS virus during replication in pigs under 
experimental conditions. Animals were inoculated with a plaque-cloned virus derived 
from VR-2332, the North American PRRS virus prototype. Three independent lines of in 
vivo replication were maintained for 367 days by pig-to-pig passage of virus at 60 day 
intervals. A total of 315 plaque-cloned viruses were recovered from 21 pigs over the 367 
day observation period and compared to the original plaque-cloned virus by virus 
neutralization assay, monoclonal antibody analysis, and sequencing of open reading 
frames (ORFs) lb (replicase), 5 (major envelope protein), and 7 (nucleocapsid) of the 
genome. Variants were detectable by day 7 post inoculation and multiple variants were 
present concurrently in every pig sampled over the observation period. Sequence 
analysis showed ORFs lb and 7 to be highly conserved. In contrast, sequencing of ORF 
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5 disclosed 48 nucleotide variants which corresponded to 22 amino acid variants. 
Although no epitopic changes were detected under the conditions of this experiment, 
PRRS virus was shown to evolve continuously in infected pigs, with different genes of 
the viral genome undergoing varying degrees of change. 
Introduction 
Porcine reproductive and respiratory syndrome (PRRS) first appeared as 
catastrophic, uncontrollable, clinical outbreaks in swine herds in North America, Europe, 
and Asia in the late 1980's and early 1990's (Chang et al., 1993; Collins et al., 1992; 
Kuwahara et al., 1994; Wensvoort et al., 1991). The etiology of PRRS was established in 
1991 when a previously unrecognized virus was identified as the causal agent 
(Wensvoort et al„ 1991). 
Porcine reproductive and respiratory syndrome virus is a member of family 
Arteriviridae with equine arteritis virus (EAV), lactate dehydrogenase-elevating virus 
(LDV) of mice, and simian hemorrhagic fever virus (SHFV) (Cavanagh 1997; Pringle 
1996). Although smaller in size and lacking the surface projections characteristic of 
coronaviruses, the arteriviruses are classified in order Nidovirales with family 
Coronaviridae because of common traits in genomic organization and replication strategy 
(Cavanagh 1997; Conzelmann et al., 1993; Meulenberg et al., 1993a; Pringle 1996). 
PRRS virus is enveloped and has a polyadenylated, single-stranded, non-segmented, 
positive-sense RNA genome 15 kilobases in size (Benfield et al., 1992; Conzelmann et 
al., 1993; Meulenberg et al. 1993b; Meulenberg et al., 1994). The genome consists of 8 
open reading frames (ORFs) that are expressed through the production of a nested set of 
subgenomic 3' co-terminal mRNAs (Conzelmann et al., 1993; Meulenberg et al., 1993b; 
Meulenberg et al., 1994). ORF 1, which comprises two-thirds of the genome, encodes 
for the viral RNA-dependent RNA polymerase (Conzelmann et al., 1993; Meulenberg et 
al., 1993a). ORFs 2 to 7 are postulated to encode for structural proteins, but only 3 
proteins have been consistently identified in virions and/or lysates of virus-infected cells. 
These 3 are the 15kD nucleocapsid (N), 19kD matrix (M), and 25kD envelope (E) 
glycoproteins that are encoded by ORFs 7,6, and 5, respectively (Nelson et al., 1993; 
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Nelson et al., 1994). Proteins encoded by ORFs 2 to 4 are designated GP2, GP3, and 
GP4, where 'GP' indicates 'glycoprotein' and the number designates the ORF from 
which it is derived (Meulenberg et al., 1995; Van Nieuwstadt et al., 1996). 
In swine, infection with PRRS virus produces a viremia with subsequent 
dissemination and viral replication in multiple organs (Rossow et al., 1995, 1996). The 
virus replicates predominantly in cells of the monocyte/macrophage lineage (Pol et al., 
1991; Rossow et al., 1995, 1996; Wensvoort et al., 1991). Clinically, infection may be 
totally inapparent or cause severe disease. Generally, clinical signs involve reproductive 
disorders in pregnant animals and/or respiratory disease in pigs of all ages (Christianson 
et al., 1992; Halbur et al., 1996a, b; Hooper et al., 1992; Pol et al., 1991; Rossow et al., 
1994; Yoon et al., 1992). Reproductive disease in pregnant animals is manifested as late-
term abortions or premature farrowings. Affected litters have a higher proportion of 
stillborn and weak born piglets and increased preweaning mortality (Christianson et al., 
1992; Hopper et al., 1992; Yoon et al., 1992). 
PRRS virus produces a persistent infection despite an active immune response 
(Albina et al., 1994; Benfield et al., 1997; Halbur et al., 1995; Halbur et al., 1996a; 
Larochelle et al., 1996; Wills et al., 1997). The PRRS virus carrier state was first 
recognized in an experiment that documented transmission of virus from animals infected 
99 days earlier to commingled sentinel pigs (Zimmerman et al., 1992). Subsequently, 
Wills et al. (1997) reported isolation of virus up to 157 days post inoculation. Persistence 
is an important epidemiological feature because it provides a ready means for PRRS virus 
to perpetuate itself through a cycle of transmission from carrier to susceptible animals. 
As a consequence, elimination of PRRS virus from herds is difficult and cyclic bouts of 
PRRS virus-associated health problems are commonplace. 
The mechanism(s) by which the virus persists in the host is(are) not known, but 
PRRS viruses are characterized by a high degree of genetic and antigenic variation. 
Feasibly, persistence in the host and viral diversity could be two manifestations of the 
same function. Genetic analyses have shown the existence of at least two major virus 
genotypes, the European and the North American, with extensive genetic variation both 
within and between these genotypes. Nelsen, et al. (1999) found important differences 
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between the prototypic North American (VR-2332) and European (Lelystad) viruses in 
the 5' leader sequence and parts of ORF la. Marked differences were also found between 
European and North American isolates in some structural genes (Kapur, et al., 1996; 
Murtaugh, et al., 1995). ORF 7 is highly conserved among North American isolates with 
95 to 100 percent amino acid homology, but a comparison of North American viruses and 
Lelystad virus found only 57 to 59 percent amino acid homology (Meng et al., 1995a; 
Murtaugh et al., 1995). ORF 6 is the most conserved gene among North American 
isolates with up to 100 percent amino acid identity and the most conserved between 
North American and European isolates with 70 to 81 percent identity (Kapur et al., 1996; 
Meng et al., 1995b; Murtaugh et al., 1995). The amino acid sequence homology of ORF 
5 varies from 88 to 97 percent among North American isolates and from 51 to 59 percent 
when comparing North American viruses to the Lelystad virus (Andreyev et al., 1997; 
Kapur et al., 1996; Meng et al., 1994; Murtaugh et al., 1995). A comparison of the 
Lelystad virus with isolate ATCC VR-2332, the North American prototype virus, found 
an amino acid identity of 63. 58, and 68 percent for ORFs 2, 3, and 4. respectively 
(Murtaugh et al.. 1995). Similar results were reported when comparing the Lelystad virus 
with U.S. isolate VR-2385 (Morozov et al., 1995). 
Genetic diversity is mirrored in antigenic diversity among PRRS virus isolates. 
Antigenic variation was initially demonstrated in a comparison of European and North 
American isolates. Using an immunoperoxidase monolayer assay (IPMA), Wensvoort et 
al. ( 1992) evaluated the reactivity of polyclonal porcine antibodies raised against either 
Lelystad virus or North American isolate ATCC VR-2332 with PRRS virus isolates from 
around the world. The investigators were able to differentiate European from North 
American isolates on the basis of differences in IPMA antibody titers. That is, 
significantly higher antibody titers were obtained in the homologous assay system. Later 
studies found even greater antigenic diversity among PRRS virus isolates than initially 
suspected (Bautista et al., 1993; Dea et al., 1996; Drew et al., 1995; Yoon et al., 1995). 
Yoon et al. (1995) examined 22 PRRS virus isolates from 8 different U.S. states 
recovered from samples collected between 1989 and 1993. Using a panel of 5 
monoclonal antibodies (Mabs) specific for the N protein, the 22 virus isolates fell into 
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one of 3 groups based on their reactivity pattern. Yang et al. (1999) expanded this study 
to 70 North American isolates from samples collected between 1989 and 1995 and a 
panel of 23 Mabs against the N protein. Their results showed 5 antigenic groups, with 
the European Lelystad virus representing an antigenic group distinct from any of the 
North American groups identified. Furthermore, using antibodies against discontinuous 
epitopes of the N and M proteins and continuous epitopes of the E and GP3 proteins, the 
65 North American isolates in the first and second antigenic groups (lis and II15) were 
further subdivided into 9 and 4 antigenic subgroups, respectively (Yang et al., 2000). 
That field isolates of PRRS virus show a remarkable degree of genetic and 
antigenic variability has become abundantly evident. Understanding the source and 
degree of virus diversity is important because of its potential impact on viral virulence, 
persistence in the host, protective immunity, and even on our ability to diagnose the 
infection. The assumption is that these changes occur during the course of in vivo 
replication in swine and arise, in large part, because of errors that occur during RNA 
replication. However, the degree and rate of mutation of PRRS virus in infected pigs 
over time is not known. To address this question, we examined the genetic and antigenic 
changes that occurred in a well-characterized PRRS virus isolate during the course of 
multiple pig passages over a period of 367 days. 
Materials and Methods 
Experimental design 
The objective of the study was to characterize PRRS virus mutation during 
prolonged in vivo replication. The experiment began by inoculating pigs with a highly 
homologous inoculum of a well-characterized PRRS virus. Three independent lines (A, 
B, C) of in vivo virus replication were monitored over 7 animal passages (PI to P7). Pigs 
in a fourth line (D) served both as mock-infected negative controls and environmental 
sentinels (Figure 1). Virus was periodically recovered from individual pigs within lines 
A. B, and C over a period of 367 days and compared genetically and antigenically to the 
original PRRS virus. 
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Passage 
PRRS virus 
VR-2332-CC-01 
Negative 
control 
4/ y 
PI Pig 1A Pig IB Pig 1C Pig ID 
* * 4» 
P2 Pig 2A Pig 2B Pig 2C Pig 20 
* 4- 4» 
P3 Pig 3A Pig 3B Pig 3C Pig 3D 
4/ 4/ 4/ 
P4 Pig 4A Pig 4B Pig 4C Pig 40 
4, 4, 4, 
P5 Pig 5A Pig 5B Pig 5C Pig 5D 
4/ 4, 4/ 
P6 Pig 6A Pig 6B Pig 6C Pig 6D 
4/ 4/ 4; 
P7 Pig 7A Pig 7B Pig 7C Pig 7D 
Figure 1. Experimental design. Diagram illustrates 3 independent lines (A, B, C) and 7 
pig passages (PI to P7) of PRRS virus. Pigs 1A. IB, 1C were inoculated with 
a plaque-cloned PRRS virus. Pigs in passages P2 to P7 were inoculated with 
tissue filtrate from the corresponding pig in the previous passage. 
In passage one (PI), 3 14- to 21-day-old PRRS-free pigs (1A, IB, 1C) were 
inoculated intranasally (1 ml per naris) and intramuscularly (8 ml per pig) with a 3X 
plaque-cloned PRRS virus designated VR-2332-CC-01 at a titer of 106 50 percent tissue 
culture infective doses (TCID50) per ml. A fourth pig was (ID) was inoculated with cell 
culture medium. Animals were housed in HEPA-filtered isolation units (Barrier Systems, 
Inc., Tom River, NJ, USA) to prevent exposure to extraneous viruses. Pigs were kept for 
60days post inoculation (p.i.) during which time they were observed daily and serum 
samples collected periodically for virological and serological assays. At 60 day p.i., the 
animals were euthanized and whole blood in ethylenediamine tetraacetic acid (EDTA), 
tissues (tonsil, lung, spleen, tracheobronchial and medial iliac lymph nodes), and 
bronchoalveolar lavage were collected. For each subsequent passage after PI, 4 PRRS 
virus-free pigs were randomly assigned to the 2 groups and inoculated as described 
above, except that tissue homogenate filtrate prepared from the post mortem samples 
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collected from the pig in the previous passage was used in place of the cell culture-
derived PRRS virus inoculum. The use of tissue homogenate made it possible to expose 
animals directly to pig-adapted PRRS virus and avoid any selective pressures arising 
from isolation and replication of virus on cell culture. 
Viruses, cells, media 
The North American prototype PRRS virus ATCC VR-2332 (American Type 
Culture Collection, Manassas, VA, USA) was used in the study. VR-2332 was selected 
because the complete genomic sequence has been published (GenBank® accession no. 
PRU87392, Nelsen et al., 1999) and the epitopic profile described (Yang et al., 1999; 
Yang et al., 2000). The virus was propagated on MARC-145 cells, a clone of the African 
monkey kidney cell line MA-104 that is considered highly permissive to PRRS virus 
(Kim et al.. 1993). The cells were cultured and maintained in culture medium composed 
of Dulbecco's modified Eagle's medium (DMEM, Sigma Chemical Co., St Louis, MO, 
USA) supplemented with 10 percent fetal bovine serum (PBS, HyClone® Laboratories, 
Inc., Logan, UT, USA), 50 pg/ml gentamicin (Sigma Chemical Co., St Louis, MO, 
USA), and 0.25 ng/ml amphotericin B (Fungizone®, Sigma Chemical Co.. St Louis, MO. 
USA). 
To produce a highly homologous challenge virus, the stock virus was subjected to 
3 rounds of plaquing on MARC-145 cells. Briefly, stock virus was serially 10-fold 
diluted (i.e., 10"' to 10"*) with culture medium. Two milliliters of each dilution were 
inoculated into each well of a 6-welI plate (Coming Inc., Coming, NY, USA) containing 
24-hour-old confluent MARC-145 cells. Inoculated cells were incubated for 2 h at 37° C 
in a humidified 5 percent CO% incubator. At the end of the incubation period, the inocula 
were discarded and the cells rinsed twice with culture medium then covered with 4 ml of 
overlay medium composed of 0.2 percent agarose (FMC Byproducts, Rockland, MA, 
USA), 10 percent FBS, 50 pg/ml gentamicin, and 0.25 (ig/ml amphotericin B in DMEM. 
The cells were incubated for 3 to 7 days at 37° C in a humid 5 percent CO2 atmosphere. 
During the incubation period, well-demarcated plaques were selected and suspended in 2 
ml of culture medium, then propagated once in MARC-145 cells. This process was 
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repeated 3 times. Following the third round of plaquing, one virus clone, designated VR-
2332-CC-01 (hereafter CC-01), was selected and propagated once on MARC-145 cells to 
obtain an amount sufficient for inoculating the pigs in PI. Surplus CC-01 was aliquoted 
and stored at minus 80° C for future use. 
The same procedure was used to recover plaque-cloned virus isolates from pigs. 
That is, 15 plaque-cloned virus isolates were recovered from each of the 3 pigs in each of 
the 7 passages by directly diluting the serum samples collected on day 7 p.i. following the 
procedure described above. Use of viremic serum samples made it possible to recover 
viruses directly from pigs and eliminated the requirement for virus isolation in cell 
culture prior to plaque-cloning. This also served to reduce the selection effect of cell 
culture on the recovery of plaque-cloned viruses. Selected plaque-cloned viruses were 
propagated once in MARC-145 cells, aliquoted, and stored at minus 80° C until used. 
Fifteen plaque-cloned viruses were also obtained from the original virus inoculum to 
document the genetic and antigenic characteristics of CC-01. assess the variability of the 
virus population within the inoculum, and provide a baseline for comparisons. 
Animals and animal care 
Throughout the study, animals were housed and cared for in compliance with the 
requirements given in Guide for the Care and Use of Agricultural Animals in 
Agricultural Research and Teaching ' (Federation of Animal Science Societies). 
Crossbred pigs were obtained from a herd known to be free of PRRS virus. Pigs were 
weaned at 10-to-14 days of age, ear-tagged, and randomly assigned to a treatment. 
Weaned pigs were group-housed in HEPA-filtered isolation units for several days prior to 
exposure to virus, then individually housed in the isolation units from the time of 
exposure until the end of the observation period. The isolation units were equipped with 
internal flush mechanisms that allowed for disposal of waste products while maintaining 
a biosecure environment. Likewise, a sealed system permitted feeding without 
jeopardizing biosecurity. Contact with the external environment and other animals was 
eliminated to the greatest degree possible. Inoculations and sample collections were 
scheduled so that only one pig was removed from its isolation unit in any 24-hour period. 
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Immediately following inoculation or sample collection, the environment was cleaned 
then disinfected with chlorhexidine diacetate disinfectant (Nolvasan® Solution, Fort 
Dodge Laboratories, Fort Dodge, IA, USA). 
Biological samples 
Blood samples were collected from all pigs on days 0, 7, 14, 21,28, 35, and 60 
p.i. using a single-use blood collection system (Vacutainer® Brand, Becton Dickinson, 
Franklin Lakes, NJ, USA). After 30 min at room temperature, the serum was harvested 
by centrifuging the sample at 1000 x g for 10 min. At 60 days p.i., pigs were euthanized 
and necropsied. Whole blood, tonsil, tracheobronchial and medial iliac lymph nodes, 
spleen, lung, and bronchoalveolar lavage were collected from each individual animal. 
Whole blood samples were collected using a single-use blood collection system 
containing EDTA (Vacutainer® Brand, Becton Dickinson. Franklin Lakes, NJ, USA) and 
processed immediately after sampling to obtain peripheral blood leukocytes (PBL), as 
previously described (Pang et al., 1994). Briefly, whole blood in EDTA was centrifuged 
at 800 x g at 4° C for 30 min. The PBLs at the interface of the plasma and red blood cells 
were collected and resuspended in 3 ml of Hank's balanced salt solution (HBSS) (Sigma 
Chemical Co., St. Louis, MO, USA). The cell suspension was then layered over an equal 
volume of Histopaque®-1077 (Sigma Chemical Co., St. Louis, MO, USA) and 
centrifuged at 1200 x g at 4° C for 20 min. The PBLs at the interface of the upper 
medium layer and the lower erythrocyte layer were collected, then washed twice by 
resuspending in 10 ml of HBSS and centrifuging at 200 x g for 10 min. All samples were 
stored at minus 80° C. 
To prepare inocula for P2 through P7, biological samples (tonsil, lymph nodes, 
spleen, lung, PBLs, and lung lavage) were suspended in cold HBSS at approximately 20 
percent (w/v). The pool was homogenized in a Stomacher® 80 (Seward, London, UK) 
for 2 min and then centrifuged at 4000 x g for 30 min at 4° C. The supernatant was 
passed through a 0.2 |im non-pyrogenic nitrocellulose membrane filter (Coming Inc., 
Coming, NY, USA) and used to inoculate the next pig. 
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Enzyme-linked immunosorbent assay (ELISA) 
A commercial ELISA kit (IDEXX Laboratories, Inc., Westbrook, MA, USA) for 
the detection of antibody specific for PRRS virus was used following the directions 
supplied by the manufacturer. According to the manufacturer, samples with sample-to-
positive (S/P) ratios > 0.4 are positive for antibody against PRRS virus. 
Virus titration 
A microtitration inactivity assay was performed to assess the virus titer of the 
original inoculum, as well as the level of PRRS virus in serum samples collected over 
time from pigs in PI through P7. In brief, samples were serially 10-fold diluted (10° to 
10"6) in culture medium. One hundred |il of each dilution was added to 3 wells of a 96-
well microtitration plate (Coming, Inc., Coming, NY, USA) containing 24-hour-old 
confluent MARC-145 cell monolayers. Inoculated cells were incubated at 37° C in a 
humidified 5 percent CO, incubator. Each sample was run in duplicate. The cells were 
monitored daily for cytopathic effect (CPE) for up to 7 days. If CPE was not evident, the 
cells were fixed with 80 percent acetone aqueous solution, dried, stained with 
fluoroisothiocyanate-conjugated (FITC) monoclonal antibody (Mab) SDOW17 (Rural 
Technologies, Brookings, SD, USA) specific for the N protein of PRRS virus, and 
visualized with fluorescence microscopy. The presence of PRRS virus was determined 
based on the observation of virus-specific CPE and/or fluorescence reaction. Virus titers 
were determined using the method described by Reed and Muench (1938) and expressed 
as TCID50 per ml. 
Virus neutralization (VN) assay 
A one-way VN test using constant antibody and varying virus concentration was 
performed as described previously (Yang et al., 2000) to compare the relative 
susceptibility of pig-derived plaque-cloned virus isolates to the neutralizing activity of 
serum and to screen for potential escape-mutant viruses. A total of 105 plaque-cloned 
viruses were examined in the one-way VN assay, i.e., 15 clones from the CC-01 
inoculum, 45 clones from PI (15 clones from each of 3 pigs), and 45 clones from P7 (15 
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clones from each of 3 pigs). The PI clones represented 7 days and the P7 clones 367 
days of in vivo replication. 
To perform the assay, virus clones were serially 10-fold diluted in DMEM 
supplemented with 50 pg/ml gentamicin, and 0.25 pg/ml amphotericin B. Serum 
collected from each of 3 pigs (1A, IB, 1C) at the termination of PI (day 60 p.i.) served as 
the source of antibody. The assay was performed in duplicate for each combination of 
antibody source and virus clone. Serum samples were heat-inactivated at 56° C for 45 
min and then 1:2 diluted. Fifty pi of each diluted virus clone was mixed with an equal 
volume of diluted serum. An additional 50 pi of each diluted virus clone mixed with an 
equal volume of cell culture medium, instead of antiserum, served as an untreated 
control. All mixtures were incubated for 1 h at 37° C, and then 100 pi of each mixture 
was added to 96-well plates containing 24-hour-old confluent MARC-145 cell 
monolayers in the same manner as previously described for virus titration. Inoculated 
cells were incubated for up to 7 days. At the end of the 7-day incubation period, the virus 
titer of each clone was calculated for each plaque-clone in the presence and absence of 
antiserum and expressed as TCID50 in logto- The relative susceptibility of plaque-cloned 
viruses was calculated using the following equation and expressed as the VN index (%): 
x ™  - J  t o /  \  ( T C I D 5 0  w i t h o u t  a n t i s e r u m  -  T C I D 5 0  w i t h  a n t i s e r u m )  v  1 A _  
W todex (%) TCID50 without antiserum X 100 
Monoclonal antibody analysis 
The epitopic profile of each of 150 plaque-cloned viruses, i.e., 15 clones from the 
CC-01 inoculum, 45 clones from PI (day 7 in vivo replication), 45 clones from P2 (day 
67 in vivo replication), and 45 clones from P7 (day 367 in vivo replication) was 
determined using a panel of Mabs in an indirect immunofluorescence assay (IFA) (Yang 
et al., 1999). The panel consisted of 5 Mabs against the N protein and 2 against the E 
protein. Production and characterization of the Mabs has been described (Yang et al., 
1999; 2000). 
To prepare PRRS virus-infected monolayers, 24-hour-old confluent MARC-145 
cells in 96-well plates were inoculated with optimally diluted virus. Procedures for 
control wells were identical except that the cells were not inoculated with virus. At 24, 
41 
48, or 72 h, plates were fixed by immersion in 80 percent acetone aqueous solution for 10 
min, air dried, and stored at minus 20° C until used. Mabs used in the assay were 
optimally diluted with 0.01 M phosphate-buffered saline (PBS, pH 7.2). Individual wells 
received 40 pi of each Mab dilution, after which plates were incubated at 37° C for 45 
minutes in a humid environment. After discarding the Mab solution, plates were washed 
3 times with PBS. To visualize the presence of antigen-antibody complex, each well 
received 40 pi of 1:100 diluted goat anti-mouse IgG conjugated with FITC (Kirkegaard 
and Perry Laboratories, Gaithersburg, MD, USA), after which plates were incubated for 
45 min in a humid environment at 37° C. Plates were then washed 3 times with PBS and 
air-dried. The reactivity of each Mab with each virus clone was evaluated using 
fluorescence microscopy. 
Sequencing 
A total of 150 plaque-cloned viruses were sequenced for ORF s lb and 7, i.e., 15 
clones from the CC-01 inoculum, 45 clones from PI (day 7 in vivo replication), 45 clones 
from P2 (day 67 in vivo replication) and 45 clones from P7 (day 367 in vivo replication). 
A total of 330 virus clones were sequenced for ORF 5, including 15 clones from the CC-
01 inoculum and 45 plaque-cloned viruses collected from each of the 7 passages (n = 
315). Fifty plaque-cloned viruses from the CC-01 were included in each sequencing to 
assess the homogeneity of the inoculum. 
Viral RNA for reverse transcription-polymerase chain reaction (RT-PCR) 
amplification and sequencing was extracted from each plaque-cloned virus using the 
QIAamp* Viral RNA Mini Kit (Qiagen Inc., Valencia, CA, USA) following the protocols 
recommended by the manufacturer. The viral RNA was collected and stored at minus 
80° C until used. 
The RT-PCR of ORF lb was performed on 5 pi of extracted RNA using the 
Qiagen® OneStep RT-PCR kit according to the manufacturer's protocol (Qiagen, Inc., 
Valencia. CA, USA) using primers 8100 and VRBP2 (Table 1). Reverse transcription 
was performed for 30 min at 50° C. Reverse transcriptase was inactivated and Taq 
polymerase was activated by raising the temperature to 95° C for 15 min. PCR 
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amplification was achieved by 35 cycles of annealing at 57° C for 30 sec. extension at 
72° C for 45 sec, and denaturation at 94° C for 45 sec. Products were polished by 
incubation at 72°C for 7 min. 
For ORF 5 RT-PCR, 10 pi of extracted RNA template was added to a tube 
containing 50 pi of 2X reaction mix, 2 pi of RT/Taq mix, and 34 pi of RNase-free HiO 
(SuperScript™ One-Step RT-PCR with Platinum® Taq, Life Technologies, Grand Island, 
NY, USA), 2 pi of Prime RNase Inhibitor™ (Brinkmann. Westburg, NY. USA), 1 pi of 
P5F primer, and 1 pi of P5R primer (Table 1). The RT-PCR reaction was performed in a 
thermocycler (GeneAmp® PCR system 2400, PE Biosystems, Foster City, CA, USA) at 
50° C for 30 min, 92° C for 2 min, and then 35 cycles of denaturation at 92° C for 15 sec, 
annealing at 50° C for 30 sec, and extending at 72° C for 30 sec. After the last cycle, the 
extending period was kept at 72° C for another 2 min and then all final products were 
stored at 4° C until used. To confirm the positive reaction, 2 pi of the final products were 
separated by electrophoresis in 1 percent agarose gel (Amresco Inc.. Solon, OH. USA) in 
TBE buffer with ethidium bromide. The positive products were visualized and 
photographed under UV light and the remaining products were stored at 4° C until used. 
The ORF 7 RT-PCR procedure was identical to that described above for ORF 5 
except for the use of a pair of outer sense (P7F) and antisense (P7R) primers (Table 1), 
designed as previously reported (Christopher-Hennings, et al., 1995), and 58° C instead 
of 50° C for the annealing process. 
In every round of RT-PCR, RNA extracted from reference PRRS virus was used 
as a positive control and a mock-infected cell culture fluid as a negative control. The 
final RT-PCR products were purified using either QIAquick™ or 96-well PCR 
purification kits (Qiagen Inc., Valencia, CA, USA) following the procedures 
recommended by the manufacturer. The final purified product was collected and stored 
at 4° C until sequenced. 
Sequencing reactions for ORF lb were carried out at the University of Minnesota 
Advanced Genetic Analysis Center (St. Paul, MN, USA) using 4 pi of purified PCR 
product and 3.2 /mioles of primers RESP1BP.1 and VRBP2 (Table 1). Sequencing of 
ORF 5 and ORF 7 was done at the Iowa State University Nucleic Acid Facility (Ames, 
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IA, USA) using the appropriate amount of purified PCR product, and 5 pmols of primers. 
The primers, P5F, P5R, PS1, and PS 1R were used for ORF 5 and P7F and P7R for ORF 
7 (Table 1 ). For all 3 ORFs, pairs of primers were primed from the positions before and 
after the target sequences. However, in ORF 5, PS1 and PS1R were also used to increase 
sequence accuracy and primed from the middle of ORF 5 to both directions. 
Table 1. Primers used for PCR and sequencing 
Primers Sequences Location3 
8100 5'-CTGACTGCCCTAAACAGCTGAC-3' 8346-8367 
VRBP2 5'-CAGATGTTCAACCCACCAGT-3' 9259-9239 
RESP1BP.1 5'-CATCGCACTAGCCCACCGAGCAGTG-3' 8713-8737 
P5F 5-CCTGAGACCATGAGGTGGG-3' 13696-13714 
P5R 5-TTTAGGGCATATATCATCACTGG-3' 14459-14437 
PS1 5-AGT AGC AT CTACGCGGTCTGTGCC-3 ' 14093-14116 
PS1R 5'-CACAGACCGCGTAGATGCTACT-3' 14114-14093 
P7F 5'-TCGTGTTGGGTGGCAGAAAAGC-3' 14816-14837 
P7R 5'-GCCATTCACCACACATTCTTCC-3l 15300-15279 
1 GenBank® accession no. PRU87392, Nelsen et al., 1999 
Analysis of data 
ELISA S/P values were analyzed by fitting a regression model to longitudinal 
data (Diggle et al. 1994). An appropriate model for the time course in each pig was 
chosen using plots of the results and observations of antibody response. A simple model 
that fit the data from day 7 through day 60 was ELISA S/P = a + p log day + e. 
Differences among lines and generations were tested separately for each parameter of the 
model. 
Viremia data from days 7 to 35 were analyzed by analysis of variance (ANOVA) 
and by longitudinal regression methods. Data for days 0 and 60 were excluded because 
no virus was detected at those times. All analyses used the average of two replicate 
determinations of logio TCID$o for each pig and day. The ANOVA used a split-plot 
analysis to account for the repeated measures across days. However, because there was a 
significant three-way interaction between passage, lines (A, B, C), and day p.i., 
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longitudinal data analysis (Diggle et al. 1994) was used to find a simpler model for the 
time course of viremia in each pig. A quadratic regression, logio TCID50 = a + p day + 7 
day2 + 6, was fit to each pig. In the model, a was an intercept that was the same for all 
groups; P was the slope of the line; and y was the quadratic coefficient. The day of peak 
viremia was estimated for each pig from the quadratic regression coefficients: Dpeak = -
p/2y. Differences among lines and generations were tested separately for each parameter. 
Data from the VN assay were summarized using the mean VN index for each 
combination of isolate and PI antiserum. An escaped mutant was considered to be a 
virus clone with significantly smaller mean VN index. 
Sequence alignment, comparisons, and phylogenetic analyses were carried out 
using computer software (DNASTAR0, DNASTAR Inc., Madison, WI, USA). 
Nucleotides sequences of VR-2332 (GenBank® access no. PRU87392, Nelsen et al., 
1999) and RespPRRS® vaccine strain (GenBank® access no. AF159149, Allende et al., 
2000a) were obtained and included in the sequence analyses for comparative purposes. 
Like RespPRRS® vaccine strain, CC-01 is derived from VR-2332. Nucleotide mutation 
rates and amino acid sequence changes over the course of the experiment were calculated 
separately for ORFs lb, 5, and 7. Phylogenetic trees representing the amino acid 
variation in the envelope glycoprotein (ORF 5), and combining ORF lb, 5 and 7 
encoding proteins were computed using the Jutun Hein method with the PAM250 weight 
table (Hein, 1989). 
Results 
Clinical observations, viremia, and antibody response 
HEPA-filtered housing units, necessary to protect pigs from exposure to 
extraneous viruses, barred the investigators from contact with animals, except as required 
for sample collection. For that reason, clinical observations were based on perceptible 
changes in behavior, rather than direct examination. Following inoculation with tissue 
filtrates, all pigs in the experimental group exhibited mild to moderate lethargy and 
anorexia, occasionally with dyspnea, beginning on day 2 and occasionally lasting up to 
day 10 p.i.. All pigs appeared clinically normal thereafter. 
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ELISA-detectable antibody responses and PRRS viremia in successive passages 
(P2 to P7) showed that inoculation of pigs with tissue homogenate filtrates resulted in 
transmission of the infection. All pigs in lines A, B, and C showed a similar humoral 
immune response, as measured by ELISA (Figure 2). No statistically significant 
differences were found in the ELISA response among lines A, B, and C for any sampling 
point in time. 
All pigs in lines A, B, and C became viremic following inoculation (Figure 3). 
The data for individual pigs was fit to a quadratic equation and the day of peak viremia 
estimated for each passage and line (Table 2). Statistical analyses showed that the 
response was not the same among all lines or passages. Comparisons between the 
slopes of lines A, B, and C showed a significant difference in viremia pattern between 
I 
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o 
Days Post Inoculation 
Fig. 2. Antibody response to PRRS virus infection. Values represent means and standard 
deviations (SD) of ELISA sample-to-positive (S/P) ratios in Line A ( -*-), Line B 
(-*-), and Line C ( -*-) over all passages (PI to P7). 
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lines A and B (p = 0.0057), but no difference between A and C (p = 0.19) or B versus C 
(p = 0.13). Specific comparisons between passages also showed a highly significant 
difference (P < 0.0001) between the slope of the line in passage one versus the mean 
slope of passages 2 through 7. Higher level of PRRS viremia was quickly developed in 
pigs received tissue homogenate from PI, whereas lower level but much longer duration 
of viremia was observed in pigs inoculated with CC-01. This suggested an adaptive 
difference between cell-culture derived PRRS virus and pig-passaged PRRS virus. 
All pigs in Line D, i.e., negative controls and environmental sentinels, remained 
free of PRRS virus and virus-specific antibody throughout the experiment. These results 
provided evidence that biosecurity procedures effectively prevented the inadvertent 
transmission of PRRS viruses among pigs. 
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Fig. 3. Level and duration of viremia. Means and standard deviations in pigs (PI ) 
inoculated with cell culture-derived PRRS virus (-*-) vs pigs (P2-7) pig-
passaged virus in Line A (-#-), Line B (-*-) and Line C ( -*-). 
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Table 2. Estimated day of peak viremia by line and passage 
Passage Line A (d.p.i)a Line B (d.p.i) Line C (d.p.i.) 
ï ÏO 2Ï4 2Ô9 
2 4.1 8.7 6.2 
3 6.4 10.9 8.5 
4 6.9 11.4 9.0 
5 4.3 8.9 6.4 
6 9.0 13.5 11.1 
7 8.2 12.7 10.3 
1 days post inoculation 
Genetic characterization of the CC-01 inoculum 
Partial ORF lb sequences (435 bases), complete ORF 5 nucleotide sequences 
(603 bases) and complete ORF 7 nucleotide sequences (372 bases) were obtained for the 
15 plaque-cloned viruses derived from the CC-01 inoculum. ORFs lb, 5 and 7 sequences 
of all 15 clones were identical. This demonstrated the homogeneity of the original virus 
population and provided a baseline for comparing and contrasting virus clones recovered 
in later passages. 
Relative to VR-2332, the ORF 5 nucleotide sequence of CC-01 differed at 3 
positions: 38 (G to A), 252 (C to T), and 451 (A to G). These resulted in amino acid 
substitutions at 2 residues: 13 (arginine to glutamine) and 151 (arginine to glycine). 
Compared to RespPRRS® vaccine virus, the ORF 5 sequence of CC-01 had one 
synonymous nucleotide change at 252 (C to T). In contrast, ORF lb nucleotide sequence 
of CC-01 was identical to that of VR-2332 and RespPRRS® vaccine viruses. The ORF 
7 nucleotide sequences of VR-2332 and RespPRRS vaccine virus were identical, but CC-
01 differed in two synonymous mutations at positions 30 (G to T) and 345 (C to T). 
Assessment of genetic changes 
Sequence analysis of PRRS virus ORF 5 
Complete ORF 5 nucleotide sequences were obtained for 315 swine-derived virus 
clones (15 clones per pig; 3 pigs per passage; 7 passages). These clones represented 7, 
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67,127.187,247, 307, and 367 days of in vivo replication in passages PI through P7, 
respectively. As shown in Table 3, three or more ORF 5 nucleotide variants (5NVs) were 
detected in every pig beginning as early as day 7 p.i. In one case. 6 5NVs were recovered 
from one pig. Among the 315 virus clones, 291 differed from the CC-01 ORF 5 
nucleotide sequence. In fact, no clone with 100% homology to the CC-01 ORF 5 
sequence was detected after PI. In total, 48 5NVs, each containing from 1 to 8 
nucleotide substitutions, were observed. No nucleotide insertions or deletions were 
detected. 
Nucleotide mutations producing amino acid substitutions were observed in 289 of 
the 315 clones (Table 4). The amino acid sequence of the remaining 26 virus clones was 
identical to CC-01. No virus clone with the original CC-01 amino acid sequence was 
detected after passage Pl. A total of 22 ORF 5 amino acid variants (5AVs) were 
observed, with as many as 5 5AVs detected in a single pig. 
At both the nucleotide and amino acid levels, ORF 5 continued to mutate over the 
course of the 367-day observation period. The majority of variants were transient, i.e., 
appeared, then disappeared from later passages. The most notable exception to this trend 
was 5AV-01, which was detected in Line A at 7,67, 127, 187, 247,307, and 367 days of 
passage. No variant 'skipped' a passage(s), i.e., appeared, went undetected in a 
subsequent passage(s), and appeared in a later passage. 
The ORF 5 sequences of CC-01, VR-2332, RespPRRS® vaccine virus, and the 22 
variants were aligned and compared (Figure 4). Among the 22 variants, no specific 'hot 
spots' were identified, except at position 151 (glysine to arginine). Most amino acid 
substitutions due to nucleotide changes were observed among amino acid residues 
located between residues 10 and 34. Eleven of the 22 5AVs had amino acid substitution 
at either residues 33 (asparagine to serine) or 34 (asparatic acid to asparagine or serine), 
which is part of the ectodomain of GP5 protein. Amino acid substitution at the residue 
33 abolished postulated variable N-glycosylation site. Phylogenetic analysis (Figure 5) 
revealed two distinct branches of evolution among the 22 variants, with 8 of 9 variants 
from Line B on one branch and 13 of 14 variants from Lines A and C on the other 
branch. 
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Table 3. Chronological appearance of 48 ORF 5 nucleotide variants (5NV) within 3 
independent lines (A, B, C) and over 7 pig passages (PI to P7) 
P I *  P  2  P  3  P  4  P  5  P  6  P  7  
Variants Â B C Â B C Â B C Â B C Â B C Â B C À B C~ 
cc-oi" 5 Ï2 7 - - - - - - - : - - - - - i - i " r 
5NV-01 7 - 5 10 - 13 
5NV-02 1 
5NV-03 I - 1 
5NV-04 1 
5NV-05 I 
5NV-06 - I I 
5NV-07 I 
5NV-08 - 1 
5NV-09 »*»2 — - — - — — — — - — - — — — — — -
5NV-I0 I 
5NV-11 - I 
5 N V - 1 2  . . .  l  
5NV-I3 - 9 I 
5 N V - 1 4  . . . .  6  
5NV-I5 1 
5NV-16 14 
5NV-17 1 
5NV-18 13 
5NV-19 I 
5NV-20 I 
5NV-2I 8 
5NV-22 7 
5NV-23 - - * - - - - - 10 -13- 14 - 10 -
5NV-24 I 
5NV-25 1 
5NV-26 1 
5NV-27 I 
5NV-28 I 
5NV-29 12 
5NV-30 I 
5NV-31 I 
5NV-32 1 
5NV-33 13 
5NV-34 2 - - 15 
5NV-35 I 
5NV-36 I 
5NV-37 15 - - 14 - - 13 -
5NV-38 1 
5NV-39 I .... 
5NV-40 14 -
5NV-41 I - - -
5NV-42 3 - -
5NV-43 1 
5NV-44 1 
5NV-45 I 
5NV-46 1 -
5NV-47 14 
5NV-48 I 
Total 15 15 15 15 15 15 15 15 15 IS 15 15 15 15 15 15 IS 15 15 15 IS 
* Within passages. A, B, and C each represent one pig from which 15 plaque-cloned viruses were collected. 
b CC-01 is the original virus inoculum in PI. 
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Table 4. Chronological appearance of 22 ORF 5 amino acid variants (5AV) within 3 
independent lines (A, B, C) and over 7 pig passages (PI to P7) 
p I* P 2 P 3 P 4 P 5 P 6 P 7 
Variants ABC A B C  A B C  A B C  A B C  A B C  A B C  
13 14 15 14 
14 
i 
15 
14 
12 
-> 
13 
15 
15 
15 
15 
10 
15 
13 
15 
Total 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 
* Within passages. A, B, and C each represent one pig from which 15 plaque-cloned viruses were collected. 
b CC-01 is the original virus inoculum in PI. 
Sequence analysis of PRRS virus ORFs lb and 7 
ORF lb (polymerase) and ORF 7 (nucleocapsid) sequencing was attempted on a 
total of 135 plaque-cloned viruses, i.e., 15 clones from each of 3 pigs in PI (day 7 in vivo 
replication), P2 (day 67 in vivo replication), and P7 (day 367 in vivo replication). Partial 
sequences (435 bases) of ORF lb were obtained for 149 clones. ORF lb sequencing was 
not successful on one clone from Line A, P2. ORF 7 nucleotide sequences were obtained 
for all 135 clones. 
Relative to CC-01, a total of 16 ORF lb nucleotide variants (INVs) (Table 5) 
were observed, each containing from one to 4 nucleotide changes. In passage one, only 
one variant was detected among 45 virus clones, but all 45 viral clones from P7 were 
1 10 20 30 40//91 100//121 130 140 150 160 170 180 190 200 
CC-01 MLEKCLTAGCCSQLLSLWCIVPFCFAVLANASNDSSSHLQ//VALVTVSTAG//TCEVIRFXKNCMSWRYXCTRYTHFLLDTKGGLYRWRSPVIIEKRGKVEVEGHLIDLKRWLDGSVATPITRVSA£QWGRP 
5AV01 // // R 
SAV02 A // // 
5AV03 8 // // R 
5AV04 S U // 
5AV05 // II R 
5AV06 F P //...A // R 
5AV07 Y // // R 
SAVOB V V // // R 
5AV09 X M // II R 
5AV10 Y N // II R R 
5AV11 A N // // R 
5AV12 Y II II R 
5AV13 Y 8 U U R 
5 AVI 4 Y 8...N II II R 
5AV15 Y A N // // R 
5AV16 // // L R 
5AV17 V A N. . .0. .//. . .A // R 
5 AVI 6 // II R V. 
5AV19 // // H R 
5AV20 Y.R 8 II II R 
5AV21 Y 8 // II H R 
5AV22 Y IL IL R A 
VR-2332 R Il Il R 
ReepPRRS U Il 
Fig. 4. Amino acid sequence comparisons of VR-2332-CC-01, 22 amino acid variants, VR-2332, and RespPRRS® vaccine 
virus. Dots indicate bases identical to CC-01 ; letters indicate amino acid substitutions; positions 41 -90 and 101-120 
have been truncated. VR-2332 ORF 5 sequence obtained from GenBank® (PRU87392) and Nelsen et al., 1999. 
RespPRRS® vaccine virus sequence obtained from GenBank® (AF159149) and Allende et al., 2000a. 
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5AV-04 (BC) 
5AV-05 (C) 
5AV-02 (A) 
5AV-17 (C) 
5 AV-11 (C) 
5AV-15 (C) 
5AV-16 (À) 
5AV-19 (A) 
5AV-03 (AC) 
5AV-22 (C) 
5AV-12 (AC) 
5AV-06 (A) 
5 AV-18 (À) 
5AV-01 (AC) 
5AV-21 (B) 
5AV-20 (B) 
5AV-13 (B) 
5AV-14 (B) 
5AV-10 (B) 
5AV-09 (B) 
5AV-07 (BC) 
5AV-08 (B) 
Fig. 5. Phylogenetic relationship of 22 PRRS virus ORF 5 amino acid variants (5AVs) 
detected during 367 days of in vivo replication based on J. Hein method. Letters 
(in parentheses) represent the lines (A, B, C) of pig passage in which the variant 
was recovered. Solid lines represent the distance from ancestor (CC-01); dotted 
lines indicate a negative branch length. 
variants. All nucleotide changes were randomly distributed and only one ORF lb amino 
acid variant (1 AV) was found. Specifically, the mutation at position 207 (T to C) in one 
virus clone recovered from Line A, P7 resulted in an amino acid substitution (valine to 
alanine). The remaining nucleotide mutations were synonymous. 
ORF 7 nucleotide sequencing found no changes in 107 of the 135 pig-derived 
virus clones when compared to CC-01. Nine ORF 7 nucleotide variants (TNVs) were 
detected among the 28 remaining clones (Table 7), with each 7NV containing one or 2 
nucleotide changes at various positions. Analysis of the sequences found amino acid 
substitutions corresponding to nucleotide mutations in 8 of the 28 clones resulted in 3 
ORF 7 amino acid variants (7AVs) as summarized in Table 8. Amino acid substitutions 
in the 3 amino acid variants occurred at residues 15 (asparagine to lysine), 128 
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(glutamine to arginine), or 239 (lysine to arginine). The disappearance of 7AV-01 and 
7AV-02 from subsequent passages suggests that these variants underwent negative 
selection. 
Table 5. Appearance of 16 ORF lb nucleotide variants (1NV) within 3 independent line 
(A, B, C) and in pig passages (PI, P2 and P7) 
P 1* P 2 P 7 
Variants A B C a" B C A B C 
CC-0 Ie 14 15 15 -> 13 6 - - -
INV-01 I - - - - - - -
INV-02 - - 9 - - - - -
INV-03 - - 1 - - - - -
1NV-04 - - 2 - - - - -
INV-05 - - - 1 - - - -
INV-06 - - - 1 - - - -
INV-07 - - - - 6 - - -
1NV-08 - - - - 1 - - -
1NV-09 - - - - 2 - - -
1NV-10 - - - - - 6 - -
1NV-II - - - - - 3 - -
1NV-12 - - - - - 5 - -
1NV-13 - - - - - 1 - -
1NV-I4 - - - - - - 14 -
1NV-15 - - - - - - 1 -
INV-16 
- -
- -
-
- -
15 
Total 15 15 15 14 15 15 15 15 15 
'Within passages, A, B, and C each represent one pig from which 15 plaque-cloned viruses were collected. 
b Sequencing was successful on 14 of the 15 clones. 
c CC-01 is the original virus inoculum in PI. 
Table 6. Appearance of one ORF lb amino acid variants (1AV) within 3 independent 
lines (A. B, C) and in pig passages (PI, P2 and P7) 
P 1* P 2 P 7 
Variants A B C Ab B C A B C 
CC-0 Ie 
1AV-01 
15 15 15 14 15 15 14 
I 
15 15 
Total 15 15 15 14 15 15 15 15 15 
' Within passages, A, B, and C each represent one pig from which 15 plaque-cloned viruses were collected. 
b Sequencing was successful on 14 of the 15 clones. 
c CC-01 is the original virus inoculum in PI. 
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Table 7. Appearance of 9 ORF 7 nucleotide variants (7NV) within 3 independent lines 
(A, B, C) and in pig passages (PI, P2 and P7) 
P Is P 2 P 7 
Variants A B C A B C A B C 
CC-01" 15 15 13 13 14 13 9 15 -
7NV-01 - - 1 - - - - - -
7NV-02 - - I - - - - - -
7NV-03 - - - 1 - - - - -
7NV-04 - - - I - - - - -
7NV-05 - - - - 1 - - - -
7NV-06 - - - - - 1 - - -
7NV-07 - - - - - 1 - - -
7NV-08 - - - - - - 6 - -
7NV-09 
- - - - - - - -
15 
Total 15 15 15 15 15 15 15 15 15 
'Within passages. A, B, and C each represent one pig from which 15 plaque-cloned viruses were collected. 
b CC-01 is the original virus inoculum in PI. 
Table 8. Appearance of 3 ORF 7 amino acid variants (7AV) within 3 independent lines 
(A, B, C) and in pig passages (PI, P2 and P7) 
P 1' P 2 P 7 
Variants A B C A B C A B C 
CC-0lb 
7AV-0I 
7AV-02 
7AV-03 
15 15 14 
1 
15 15 14 
I 
9 
6 
15 15 
Total 15 15 15 15 15 15 15 15 15 
1 Within passages. A, B. and C each represent one pig from which 15 plaque-cloned viruses were collected. 
b CC-01 is the original virus inoculum in PI. 
Collective sequence analysis 
Genetic variation and evolution of CC-01 during animal passages was further 
characterized by combining the sequence data on ORFs lb, 5, and 7. Among the 45 virus 
clones recovered from PI, 44 from P2, and 45 from P7, a total of 40 combination 
nucleotide variants (CNVs) and 19 combination amino acid variants (CAVs) were 
identified (Tables 9, 10). Thirteen CNVs and 9 CAVs were detected among the 45 virus 
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clones recovered at passage P7, i.e., after, a total of 367 days of in vivo replication. Most 
variants underwent negative selection and disappeared from succeeding passages, but 
CAV-01 was detected in each Line A pig in passages PI, P2, and P7. Phylogenetic 
analysis (Figure 6) showed that these CAVs followed 2 distinct evolutionary directions. 
Similar to what was observed in ORF 5, of the 19 CAVs, 5 of 6 variants from line B were 
on one branch, while 12 of 13 variants from Lines A and C were on the other. 
Rate and types of mutation 
All sequences were compared to CC-01 and the mutation rates of ORF lb. 5 and 7 
were calculated (Figure 7). Very gradual increase in nucleotide changes occurred in ORF 
lb (435 bases) of PRRS virus over 7 animal passages (Figure 7A). At the termination of 
study, mean percent nucleotide changes among 45 plaque-cloned viruses of P7 was 
0.67% compared to CC-01. However, most of nucleotide changes were synonymous 
mutations, i.e., no amino acid substitution. The ORF 7 gene (372 bases) of PRRS virus 
was also conserved during serial animal passages (Figure 7C). In comparison to CC-01, 
the mean percent change among virus clones examined at each passage were 0.01%, 
0.03%, and 0.13% at nucleotide level and 0.02%, 0.02%, and 0.11% at amino acid level 
for passages 1, 2, and 7, respectively. 
The ORF 5 gene (603 bases) of PRRS virus showed higher rate of changes during 
animal passages (Figure 7B). Mean percent changes of nucleotides through 7 passages 
were 0.09%. 0.29%, 0.53%, 0.69%, 0.61%, 0.89%, and 0.70% in PI through P7. 
respectively. Most of nucleotide changes in ORF 5 were non-synonymous mutations, 
resulting in substitution of amino acid residues. Rates of changes in ORF 5 at deduced 
amino acids were 0.24%, 0.77%, 1.49%, 1.32%, 1.01%, 1.67%, and 1.24% at P 1 through 
P7, respectively. 
Type of mutations occurred in ORFs lb, 5, and 7 during animal passages is 
summarized in Tables 11 and 12. Overall, the transitions (G<-»A or T<->C) were more 
common to occur than the transverison (GA «-> TC). The number of transitions per 
plaque-cloned virus over passages was consistent with the mutation rates of nucleotide 
sequences in their corresponding genes, since the transversion only occurred in a few 
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Table 9. Appearance of 40 ORF lb, 5 and 7 combination nucleotide variants (CNVs) 
within 3 independent lines (A, B, C) and in pig passages (PI, P2 and P7) 
P 1* P 2 P 7 
Variants A B C A" B C A B C 
CC-0 Ie 5 12 6 - - - - - -
CNV-0 ! 6 - 4 I - 5 - - -
CNV-02 I - - - - - - - -
CNV-03 I - 1 - - - - - -
CNV-04 1 - - - - - - - -
CNV-05 1 - - - - - - - -
CNV-06 - 1 - - - - - - -
CNV-07 - I 1 - - - - - -
CNV-08 - I - - - - - - -
CNV-09 - - 1 - - . - - -
CNV-10 - - 1 - - - - - -
CNV-II - - I - - - - - -
CNV-12 - - - 8 - - - - -
CNV-I 3 - - - 1 - - - - -
CNV-I 4 - - - I - - - - -
CNV-I 5 - - - 1 - - - - -
CNV-I 6 - - - 1 - - - - -
CNV-I 7 - - - I - - - - -
CNV-I 8 - - - - 6 - - - -
CNV-I 9 - - - - 6 1 - - -
CNV-20 - - - - I - - - -
CNV-21 - - - - 1 - - - -
CNV-22 - - - - 1 - - - -
CNV-23 - - - - - 5 - - -
CNV-24 - - - - - 1 - - -
CNV-25 - - - - - 1 - - -
CNV-26 - - - - - 1 - - -
CNV-27 - - - - - 1 - - -
CNV-28 - - - - - - 4 - -
CNV-29 - - - - - - 1 - -
CNV-30 - - - - - - 3 - -
CNV-31 - - - - - - t - -
CNV-32 - - - - - - 1 - -
CNV-33 - - - - - - 1 - -
CNV-3 4 - - - - - - 4 - -
CNV-35 - - - - - - - 3 -
CNV-36 - - - - - - - 10 -
CNV-37 - - - - - - - 1 -
CNV-3 8 - - - - - - - I -
CNV-39 - - - - - - - - 14 
CNV-40 - - - - - - - - 1 
Total 15 15 15 14 15 15 15 15 15 
* Within passages. A, B, and C each represent one pig from which 15 plaque-cloned viruses were collected. 
b One clone was excluded from the analysis due to failure in sequencing of ORF lb. 
c CC-01 is the original virus inoculum in PI. 
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Table 10. Appearance of 19 ORF lb, 5 and 7 combination amino acid variants (CAVs) 
within 3 independent lines (A. B, C) and in pig passages (PI, P2 and P7) 
PI* P2 P7 
Variants A B C A" B C A B C 
CC-01' 6 14 7 - - - - -
CAV-01 7 - 4 12 - 13 - -
CAV-02 I - - - - - - -
CAV-03 I - ! - - - - -
CAV-04 - 1 1 - - - - -
CAV-05 - - 1 - - - - -
CAV-06 - - 1 - - - - -
CAV-07 - - - 2 - - - -
CAV-08 - - - - 6 - - -
CAV-09 - - - - 9 - - -
CAV-10 
- - - - - 1 - -
CAV-11 - - - - - 1 - -
CAV-12 - - - - - - 4 - -
CAV-13 - - - - - - I - -
CAV-14 - - - - - - 4 - -
CAV-15 - - - - - - 1 - -
CAV-16 - - - - - - - 13 -
CAV-17 - - - - - - - 1 -
CAV-18 - - - - - - - 1 -
CAV-19 
- - -
-
- - - - 15 
Total 15 15 15 14 15 15 15 15 15 
* Within passages. A, B, and C each represent one pig from which 15 plaque-cloned viruses were collected. 
b One clone was excluded from the analysis due to failure in sequencing of ORF lb. 
c CC-01 is the original virus inoculum in PI. 
isolates. While ORFs lb and 7 were relatively conserved during serial animal passages, 
ORF 5 showed stable increases in the substitution per clone from 0.58 to 3.87 for PI 
through P7. 
Assessment of antigenic changes 
A panel of 5 Mabs specific to the nucleocapsid (N) and 2 to the envelope (E) 
proteins was used to detect the change in epitopic profile of CC-01 during virus evolution 
in animal passages. No abolition of reactivity with each of these Mabs was observed in 
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any of plaque-cloned virus isolates of 45 each that were collected from passages 1, 2 and 
7, respectively, demonstrating no correlation between observed amino acid substitutions 
and epitopic changes. Likewise, one-way VN assay did not reveal the presence of 
plaque-cloned viruses significantly resistant to neutralizing activity of antisera collected 
at day 60 p.i. in the first passage, suggesting that no escape mutant was generated during 
7 animal passages under conditions of this experiment. 
. CAV-02 (A) 
P CAV-06 (C) 
I CAV-04 (BC) 
CAV-03 (AC) 
i CAV-13 (A) 
CAV-Ii (C) 
CAV-05 (C) 
CAV-0! (AC) 
1 CAV-12 (A) |~ CAV-14 (A) 
CAV-07 (A; 
CAV-19 (C) 
CAV-18 (B) 
CAV- 17(B) 
CAV-16 (B) 
CAV-10 (C) 
I CAV-08 (B) 
1 CAV-09 (B) 
Fig. 6. Phylogenetic relationship of 19 PRRS ORF lb, 5 and 7 combination amino acid 
variants (CAVs) based on J. Hein method. Letters (A, B, C) represent the line(s) 
of pig passage in which the variant was detected during 367 days of in vivo 
replication. Solid lines represent the distance from ancestor CC-01 ; dotted lines 
indicate a negative branch length. 
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2.0 
ORF lb 
0.5 
0.0 
2.0 
ORF 5 
0.5 
0.0 
X X 
ORF 7 
0-5 -
1 2 3 4 5 6 7 
Passages 
Fig. 7. Mutation rates of PRRS virus ORFs lb, 5 and 7 over 7 animal passages (367 
days of in vivo replication). The mutation rates were calculated as proportion of 
substitutions per each plaque-cloned virus and represented as mean percent 
change based on nucleotide (-*-) and amino acid level (-o). Each symbol 
represents mean of mutation rates among 45 cloned isolates, except 44 cloned 
viruses in P2 for ORF lb. The error bar is standard error of the difference. 
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Table 11. Mean number of nucleotide substitutions per plague-cloned virus in ORF 5 
(603 bases) of PRRS virus during 7 animal passages (PI through P7) 
Type Pla P2 P3 P4 P5 P6 P7 
Transition 0.58 1.69 3.24 3.91 3.38 4.73 3.87 
(0.11)" (0.13) (0.06) (0.10) (0.15) (0.14) (0.11) 
Transversion 0 0.02 0 0 0.33 0.67 0.33 
(0) (0.02) (0) (0) (0.07) (0.07) (0.33) 
a 45 plaque-cloned viruses were collected from each passages. 
b standard error of the difference 
Table 12. Mean number of nucleotide substitution per plaque-cloned virus in ORF lb 
(435 bases) and ORF7 (372 bases) of PRRS virus in animal passages (PI, P2 
and P7) 
Type 
ORF lb ORF 7 
Pla P2b P7 PI P2 P7 
Transition 0.02 
(0.02)c 
0.57 
(0.08) 
2.58 
(0.19) 
0.33 
(0.07) 
0.59 
(0.04) 
0.47 
(0.08) 
Transversion 0 
(0) 
0 
(0) 
0.33 
(0.07) 
0.02 
(0.02) 
0.02 
(0.02) 
0 
(0) 
a 45 plaque-cloned viruses were collected from each passages 
b 44 plaque-cloned viruses were used in the assessment due to failure to sequence one of 
45 clones. 
c standard error of the difference 
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Discussion 
The purpose of this study was to describe the evolution of PRRS virus over time. 
Genetic and antigenic changes in a well-characterized PRRS virus isolate were 
documented during the course of multiple pig passages over a period of 367 days under 
experimental conditions. 
Several strengths of the experimental design are worth noting. First, a plaque-
cloned virus inoculum, i.e.. a uniform virus population, rather than a whole virus isolate 
composed of multiple variants (quasispecies), was used to initiate the infection in passage 
one. This provided a definitive ancestor against which to compare and contrast 
descendent isolates. Second, in passages 2 to 7, the use of tissue homogenates to pass 
virus directly from pig-to-pig circumvented selection pressures arising from in vitro 
isolation and propagation of viruses. Third, recovery of 15 plaque-cloned isolates 
directly from serum made it possible to randomly sample the population of PRRS virus 
variants circulating in each pig and characterize their distribution. Fourth, the 60-day 
passage allowed the immune system to respond and extert selective pressure on the virus 
population. Fifth, the use of HEPA-filtered housing systems and adherence to strict 
biosecurity procedures made it possible to maintain virus evolution in three independent 
lines (replicates) of pig passage. This model may also be applicable to the study of the 
evolution of other single-stranded, positive-sense RNA viruses. 
Successful transmission of PRRS virus via tissue samples collected at 60 days 
post inoculation provided additional evidence that PRRS virus infection persists in swine. 
However, it was observed that cell-adapted virus behaved much differently in pigs than 
pig-adapted viruses. That is, inoculation of pigs in passage one with a cell-adapted clone 
derived from ATTC VR-2332 produced a strikingly different pattern of viremia, both in 
virus titer and duration of viremia, tthan was observed in passages 2 to 7 (Figure 3). 
These data are important because they suggest that the results of experiments may differ 
significantly depending on whether cell-adapted or pig-adapted viruses were used. 
Although no genetic basis for this biological difference was discovered, it is 
recommended that future studies with direct application to the field utilize PRRS viruses 
with a minimum a cell-culture adaptation. 
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To date, no specific genetic markers have been linked either to attenuation or 
virulence of PRRS virus. However, it is interesting to note the consistent substitution of 
a glycine residue with arginine at position 151 of ORF 5 in all virus clones after just one 
passage in pigs (Figure 4). This change represents a reversion to the amino acid residue 
of the parental strain VR-2332, a field isolate. Both PRRS virus CC-01 and RespPRRS® 
vaccine virus were derived from VR-2332 through cell culture passage and, among the 
ORFs sequenced, shared 100 percent amino acid homology. Reversion of the amino acid 
residue at position 151 of ORF 5 has been reported in RespPRRS® vaccine virus and VR-
2332 (Allende et al., 2000a; Nelsen et al., 1999; Storgaard et al., 1999; Wesley et al 
1999). Cumulatively, these results lead us to speculate that the glycine residue at the 
position 151 of ORF5 may be a marker for cell culture adaptation. Whether such this 
specific change affects virulence or in vivo replication of PRRS virus remains to be 
determined. 
The results of this study demonstrated that PRRS virus evolves continuously in 
infected pigs, with different genes of the viral genome undergoing varying degrees of 
change. As anticipated for a house-keeping gene, PRRS virus ORF lb, which encodes 
the RNA polymerase, was highly conserved. ORF 7 (nucleocapsid) was also conserved 
during animal passages relative to ORF 5 (envelope), suggesting that the internal 
structural protein is genetically more stable than the external structural protein(s). This 
may be due to the immune pressures to which the external structural proteins are 
exposed. The relatively low rate of mutation observed in ORFs lb and 7 is consistent 
with field observations (Andreyev et al., 1997; Goldberg et al., 2000; Suarez et al., 1996). 
Relative to ORFs lb and 7, ORF 5 mutated at a much higher rate and numerous 
genotypes (i.e., quasispecies) were identified, with mutiple genotypes present 
concurrently in all pigs. Based on an analysis of algorithms for 
hydrophobicity/hydrophilicity and surface probability, 6 potential antigenic sites were 
identified on the surface of the GP5 protein of both North American and European 
isolates (Andreyev et al., 1997; Pirzadeh et al., 1998). Sequence analyses of field isolates 
of PRRS virus have revealed that variable regions are located among amino acid residues 
either near to the N terminus (3-39) or C-terminus (164-200) whereas the most conserved 
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regions (II to IV) are located between amino acid residues around 40 to 163 (Andreyev et 
al., 1997: Pirzadeh et al., 1998). In agreement with previous reports, our study found a 
high degree of amino acid substitutions between residues 10 and 34, which contains the 
signal peptide (I to 31) and one variable N-linked glycosylation site, whereas zero to a 
few inconsistent changes were observed in amino acid residues 40 through 160. Many 
ORF 5 variants had amino acid substitutions at residues 33 (asparagine to arginine) or 34 
(asparatic acid to asparagine or arginine). Since amino acids at 33 and 34 are known to 
be a part of the ectodomain of GP5 protein, any change in this region may affect the re­
linked glycosylation or the conformation of GP5, which is important for interaction with 
the M protein (Mardassi et al., 1995a,b; Meng et al., 1995a; Kapur et al., 1996; Pirzadeh 
et al., 1998; Pirzadeh and Dea, 1997,1998; Gonin et al., 1999). Theoretically such a 
change could result in the loss of epitope or an alteration in the immune response, but no 
such changes were found in this study. 
The appearance of ORF 5 quasispecies during in vivo replication suggests a 
potential role for mutation in viral persistence. However, the overall mutation rate of 
ORF 5 was lower than was expected on the basis of the degree of diversity seen in field 
isolates (Kapur et al., 1996). The low rate of mutation in ORF 5 suggests that on-going 
mutation is not the mechanism by which PRRS virus eludes the immune system and 
persists in pigs. 
It is believed that North American and European PRRS viruses were derived from 
a common LDV-iike ancestor (Nelsen et al., 1999). Based on the relatively low rate of 
mutation observed in this study and the 25 percent and 36 percent amino acid divergence 
in ORF lb and 7 between strain VR-2332 and the Lelystad virus (Murtaugh et al., 1995; 
Nelsen et al., 1999), we conclude that these viruses diverged in the very distant past and 
experienced independent evolutionary events. Given that the earliest evidence places the 
introduction of PRRS virus into domestic swine in 1979 (Carman, et al.. 1995), the slow 
rate of mutation documented in this study suggests that the extensive antigenic and 
genetic diversity observed in PRRS virus field isolates cannot be fully explained simply 
as a function of mutations. Alternate hypotheses to explain the variability observed in 
field isolates would include recombination, as shown among field isolates (Kapur et al 
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1996) or in vitro (Yuan et al 1999), and possible on-going evolution in alternate host 
species (Zimmerman et al., 1997). At present, factors and conditions contributing to the 
diversity of PRRS viruses remain to be established. 
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GENERAL CONCLUSIONS 
Conclusions 
In this study, we successfully established an in vivo animal model for the study of 
the evolution for porcine reproductive and respiratory syndrome (PRRS) virus which may 
be applicable to study the evolution of other positive-sense single-stranded RNA viruses. 
The particular strengths of the experimental design included the following: 
• A plaque-cloned virus inoculum, i.e., a uniform virus population instead of whole 
virus isolate containing multiple variants (quasispecies), was used to inoculate 
pigs in passage one (Domingo et al., 1996; Domingo and Holland, 1997). This 
provided a definitive ancestor against which to compare descendent isolates from 
the three independent lines of passage. 
• The use of tissue homogenates to pass virus directly from pig-to-pig circumvented 
selection pressures arising from in vitro isolation and propagation of viruses. 
• Isolation of plaque-cloned isolates directly from serum made it possible to 
randomly sample the population of PRRS virus variants within a pig without bias 
and in a single step. 
• Use of HEPA-filtered isolation systems and adherence to strict sampling protocols 
made it possible to maintain the integrity of the experiment and prevent 
inadvertent introduction or transmission of viruses among pigs. 
Because of the experimental design and the conditions under which it was 
conducted, it was possible to analyze the data and develop observations and conclusions 
with a high degree of confidence. These may be summarized as follows: 
• We observed that cell-adapted virus behaved much differently in pigs than pig-
adapted viruses. That is, inoculation of the cell-adapted strain VR-2332 produced 
a striking different viremia pattern than ones observed following adaptation to 
pigs. This observation leads us to conclude that animal studies in which highly 
cell-adapted PRRS virus was used may not be representative of the behavior of 
the virus in the field. 
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• Sequence analysis of open reading frame (ORF) 5 of 315 plaque-cloned viruses 
from passage 1 to 7 and ORFs lb and 7 of 135 cloned viruses from passages 1, 2 
and 7 showed that genes in the genome changed at varying rates. Relative to ORF 
5, ORFs lb and 7, encoding the RNA polymerase and nucleocapsid protein, were 
highly conserved as anticipated in other RNA viruses in general. A relatively low 
rate of mutation in ORFs lb and 7 is consistent with field observations (Goldberg 
et al., 2000). Specifically regarding ORF 5, the overall mutation rate was lower 
under defined conditions than was hypothesized from field observations (Kapur et 
al., 1996). This observation leads us to question the postulated role of mutation as 
a possible mechanism for eluding the immune system and establishing persistent 
infection. Yet, factors and conditions contributing to higher mutation rate remain 
to be further studied. 
• It is believed that North American and European PRRS viruses were derived from 
a common LDV-like ancestor (Nelsen et al., 1999). Based on the relatively low 
rate of mutation observed in this study and 25% and 36% amino acid divergence 
in ORF lb and 7 between strain VR-2332 and the Lelystad virus (Murtaugh et al., 
1995; Nelsen et al., 1999), we conclude that these viruses diverged in the very 
distant past and experienced independent evolutionary events. 
• Given that the earliest evidence places the introduction of PRRS virus into 
domestic swine in 1979 (Keffaber, 1989), the slow rate of mutation documented 
in this study suggests that the extensive antigenic and genetic diversity observed 
in PRRS virus field isolates cannot be fully explained simply as a function of 
mutations. Alternate hypotheses to explain the variability observed in field 
isolates would include recombination and on-going evolution in alternate host 
species. 
Future Studies 
One study is not sufficient to answer all questions concerning the remarkably broad 
genetic and antigenic diversity observed among PRRS field isolates. To the contrary, 
much more work is needed to provide a basic understanding of PRRS virus evolution and 
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to explain the diversity observed in the field. Relative to the study reported in this 
dissertation, further sequence analyses of the virus clones collected over the course of the 
experiment should be done. In particular, because of their postulated role in immunity, 
ORFs 2, 3, and 4 should be sequenced and compared. In addition, the current study 
should be extended farther in time in order to strengthen the estimates on the rate of viral 
mutation during in vivo replication. 
New areas of investigation also merit investigation. In particular, viral 
recombination and its contribution to the quasispecies pool needs elucidation. 
Theoretically, recombination among heterologous viruses could quickly generate a 
widely diverse virus population. Intragenic recombination has been noted among North 
American PRRS field isolates (Kapur et al., 1996). However, it is still unknown what 
real contribution recombination makes to PRRS virus evolution in vivo. The animal 
model we have described should be applicable to studies in this area. 
Finally, the role of alternate species and their potential to contribute to the 
diversity of isolates observed in pigs deserves consideration. Some avian species, in 
particular Anas platyrhynchos, the mallard duck, has proven to be susceptible to the 
PRRS virus with subsequent shedding of virus in the feces which was infectious to swine 
(Zimmerman et al.. 1997). Possibly, additional non-porcine hosts exist, as well. Thus, 
the role of alternative hosts in PRRS virus evolution also needs further study, as was the 
case as for evolution of influenza virus (Shaw et al., 1992). 
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